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Summary 
In eukaryotes, chromosome segregation critically depends on the establishment of 
productive contacts between kinetochores (KTs), specialized chromosomal structures, 
and the spindle microtubules (MTs). In mitosis, the spindle assembly checkpoint (SAC) 
is the major surveillance mechanism that restrains anaphase onset until all KTs become 
bi-oriented by spindle MTs. Several SAC proteins act in concert to relay the presence of 
unattached KTs to the cell cycle machinery in the cytoplasm.  The SAC protein Mad2 
plays a pivotal role in this signal transduction cascade, contributing both to the KT 
sensor and to the SAC cytoplasmic effector.  Mad2 can fold into two distinct conformers, 
Open (O) and Closed (C), and can asymmetrically dimerize. Biophysical and structural 
work had demonstrated that the conformational dynamics of Mad2 is crucial for its 
activation in vitro, but models arising from this work could not be exhaustively tested in 
cells. Here, we describe a monoclonal antibody that specifically recognizes the 
dimerization interface of C-Mad2. This antibody revealed several conformation specific 
features of Mad2 in human cells. Notably, we show that Mad2 requires association with 
its KT-receptor Mad1 to adopt the Closed conformation. Furthermore, C-Mad2 antibody 
microinjection interfered with Mad2 asymmetric dimerization and abrogated the SAC, 
accelerating mitotic progression. Remarkably, microinjection of a Mad1-neutralizing 
antibody triggered a comparable mitotic acceleration. Finally, we show that the activity 
of the Mad1:C-Mad2 complex undergoes regulation by p31comet-dependent ‘capping’. 
We also suggest that p31comet capping is negatively regulated by the SAC kinase 
Mps1 and the SAC regulator Tpr. Collectively, this work provides direct in vivo evidence 
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for the model that a KT complex of Mad1:C-Mad2 acts as a template to sustain the SAC 
and it challenges the distinction between SAC and mitotic timer. 
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Introduction 
The cell cycle and its checkpoints 
Self-reproduction is certainly the most crucial feature of cells, fundamental units 
of structure and function in living organisms. The principle that each cell arises from a 
pre-existing cell by division (“omnis cellula e cellula”) was divulgated by the pathologist 
Rudolph Virchow in the mid-19th century and laid the foundation of the modern cell 
theory. For unicellular organisms, each cell division represents the generation of two 
novel organisms arising from one. For multicellular organisms, cell division plays a 
crucial role not only in the organismic growth during development but also for the adult 
tissue homeostasis, replenishing the cellular pool otherwise depleted by the ongoing 
cell death. Mitotic cell divisions give rise to two genetically identical daughter cells and 
are always preceded by the duplication of the genetic material and other cellular 
components. The ordered series of events leading to cell division is defined as the cell 
cycle. In prokaryotes, the cell division occurs through a process called binary fission in 
which the replication of the chromosome(s) and cell growth occupy large part of the 
entire cell cycle, being rapidly followed by cell division. In eukaryotes, the two crucial 
phases of duplication (S-phase) and segregation (M-phase) of the genetic material are 
separated by so-called gap phases, G1 and G2 (Fig. 1). During G1 phase, the cell 
responds to both intra and extracellular growth signals that contribute to the decision of 
committing to one additional cell cycle, i.e. entering or not a new S phase. During G2 
phase the cell with duplicated chromosome content prepares for entering the 
subsequent M-phase (Fig. 1). G0 refers to a state in which a cell remains metabolically 
active, but no longer proliferates. The G0 state is maintained until the cell receives 
appropriate extracellular signals.  
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Figure 1. The eukaryotic cell cycle. The cell cycle is subdivided in four phases: G1, characterized by 
cell growth and by the presence of the restriction point (R), at which the decision to commit to a new cell 
cycle is taken, S in which the chromosomal DNA is replicated, G2 in which the cells prepares to divide 
and M-phase, in which the chromosome are segregated (karyokinesis) and two cells separated 
(cytokinesis). Illustration adapted from “The Encyclopaedia of Science” (www.daviddarling.info). 
 
A key principle of the cell cycle is that the underlying events occur in a controlled 
fashion displaying unidirectionality: this means that M-phase (chromosome separation) 
has always to be preceded by S-phase (chromosome duplication) and deviations would 
lead to the generation of an aberrant progeny. Key transitions in the cell cycle are 
controlled by surveillance mechanisms called checkpoints, systems that are devoted to 
monitor the correct completion of key cell cycle events and extend the duration of a 
given phase, providing time for error correction (Hartwell & Weinert, 1989). In the 
absence of perturbations the cell cycle might appear as governed by a clock, an 
autonomous oscillator dictating the duration of the different phases without any possible 
external input (Fig. 2A). When the cell cycle is perturbed, interfering either genetically or 
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chemically with the molecular devices such as the DNA replication machinery or the 
mitotic spindle apparatus, a checkpoint mediated cell cycle arrest occurs. In this 
perspective, the cell cycle appears more as a domino: a linear sequence of event in 
which the initiation of each step is dependent on the completion of the earlier step (Fig. 
2B).  
During the early days of cell cycle research questions were tackled by using 
either amphibian eggs or yeasts as model organisms. The embryological work in eggs 
seemed to support the “clock view” of the cell cycle, whereas results obtained by 
genetic approaches in yeast were consistent with the “domino model”. While increasing 
the molecular comprehension of the cell cycle machinery it became clear that the two 
views were not mutually exclusive: Cyclin protein abundances vary throughout the cell 
cycle determining changes in the activity of cyclin dependent kinases (CDKs); this leads 
in turn to the oscillation between S-phase and M-phase. Additional molecular 
components account for feedback mechanisms (usually absent during early embryonic 
development but present in somatic cells) that impose that major transitions in cyclin-
CDK behavior require completion of the events triggered by the precedent cyclin-CDK 
transition. Therefore, evidence from both traditions has contributed to a unified view of 
the eukaryotic cell cycle and the elucidation of these mechanisms led to the Nobel prize 
in Medicine awarded to Tim Hunt, Paul Nurse and Lee Hartwell in 2001.  
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Figure 2. Cell cycle control: clock and dominoes. (A) Research performed utilizing amphibian eggs 
depicted the cell cycle as the alternation of interphase and mitosis, which is controlled by an autonomous 
clock or oscillator, dictating the timing regardless of the completion of the cyclic events (independent 
pathways model). (B) Research performed utilizing yeasts supported the view that initiation of events of 
the cell cycle required the completion of the precedent set of events, in a linear pathway (dependent 
pathway model). Illustrations adapted from (Hartwell et al, 1974; Murray & Kirschner, 1989).  
 
The events of mitosis 
Mitosis or nuclear division is the phase of the cell cycle in which sister chromatids 
(the daughter DNA molecules produced in S phase) are equally segregated to the two 
daughter cells. Morphologically, mitosis can be divided into distinct phases, each of 
them involving major structural rearrangements in the dividing cell. Despite the 
comparatively primitive technology available, Walther Flemming could already in 1882 
describe the structural rearrangements typical of a dividing cell (Fig. 3A). Modern 
technology has majorly improved our ability to image living cells (Fig. 3B) and the 
various possibilities for genetic manipulation allowed an increasingly detailed molecular 
understanding of the process of cell division.  
In morphological terms, mitosis can be divided into five distinct phases: 
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Prophase: the interphase chromatin condenses. The centrosomes (cellular 
organelle that serves as the main microtubule organizing center (MTOC), which have 
been duplicated during S phase, separate and move to opposite side of the nucleus. 
There, by nucleating MTs, the initiation of spindle assembly occurs. 
Prometaphase: nuclear envelope break down (abbreviated NEBD) is 
completed. Specialized proteinaceous structures assembled at the centromeric regions 
of both sister chromatids, called kinetochores (KTs), begin establishing contacts with 
the spindle MTs. Such contacts will contribute to the movement of sister chromatids to 
the cellular equator, a process known as chromosome congression.  
Metaphase: sister chromatids have completed congression, reaching bipolar 
attachment, i.e. sister KTs establish stable interactions with MTs emanating from 
opposite spindle poles.  
Anaphase: sister chromatid cohesion is lost and sister chromatids are segregated to 
opposite poles of the spindle (anaphase A). With a variable temporal overlap, the 
spindle elongates and the poles move further apart from each other (anaphase B).  
Telophase: chromosomes decondense and the nuclear membrane reforms 
around them.  
During late mitotic stages the separation of the cytoplasms, or cytokinesis, is 
initiated. The contraction of an actin-myosinII-based ring-like structure leads to furrow 
ingression and the central spindle compacts to form the midbody. Cytokinesis is 
ultimated by abscission, in which the two cytoplasms are separated resulting in two new 
genetically identical daughter cells.  
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Figure 3 The phases of mitosis. Prophase, prometaphase, metaphase, anaphase and telophase as 
visualized by Walther Flemming (A), by modern florescence microscopy (MTs labelled in green and the 
chromatine in red) (B) and in a schematic of a modern text book (C). Pictures in (A) were adapted from 
(Paweletz, 2001), original pictures from (Flemming, 1882). Images in B are courtesy of Dr. Anna 
Santamaria, whereas schematics depicted in C were adapted from (Morgan, The Cell Cycle. Principles of 
Control).   
 
The Spindle Assembly Checkpoint (SAC) 
The major task of mitosis is to equally segregate the chromosomes to two 
daughter cells. This task relies on the establishment of productive contacts between 
sister KTs and spindle MTs emanating from opposite spindle poles, also called bipolar 
attachment. A quarter of a century ago, the ‘search and capture’ model laid the 
foundations for understanding the process of KT-MT attachment (Kirschner & Mitchison, 
1986). The model incorporated the newly discovered dynamic instability of MTs to 
propose that mitotic MTs explore the space and become selectively stabilized once they 
reach KTs as their targets. Since the process relies on the intrinsically stochastic MT 
behavior, accomplishment of bipolar attachment for all 46 pairs of sister KTs present in 
a mitotic human cell can take a variable amount of time. In order to obtain faithful cell 
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division, eukaryotic cells have evolved a surveillance pathway called spindle assembly 
checkpoint (SAC), that extends (pro-)metaphase duration until bipolar attachment is 
completed (Fig. 4). As other cell cycle checkpoints, the SAC is composed of a sensing 
system, monitoring primarily KT-MT attachment, a signal transduction module that 
relays on the attachment status away from KTs in the cellular cytoplasm, and an 
effector that regulates core components of the cell cycle machinery to generate the 
required delay. The molecular components of the SAC were discovered two decades 
ago in two independent genetic screens in the budding yeast S. cerevisiae (Hoyt et al, 
1991; Li & Murray, 1991). They are conserved among eukaryotes and include Mad1, 
Mad2, Bub1, Bub3, BubR1/Mad3 and Mps1, all localizing to KTs during mitosis in a 
dynamic fashion (reviewed in Musacchio & Salmon, 2007). The following sections will 
focus on the detailed description of our current knowledge on this pathway.  
 
. 
 
 
Figure 4 Checkpoint controls 
(also known as surveillance 
mechanisms) ensure the 
dependency of cell-cycle transitions 
on the completion of earlier events. 
They consist of three distinct sets of 
functions: sensors (which look out 
for defects and emit a signal); 
signal-transduction cascades 
(checkpoint signals need to be 
transmitted throughout the nucleus 
or cell); and effectors (a target is 
regulated to delay cell-cycle 
progression). Illustration adapted 
from (Musacchio & Hardwick, 2002) 
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The vertebrate centromere/kinetochore region, the SAC sensor 
The understanding on how the SAC can sense a proper KT-MT attachment 
cannot be put aside the detailed comprehension of the structure of KTs themselves. 
KTs are large protein assemblies built on chromosomal loci named centromeres. By 
electron microscopy, vertebrate KTs appear as trilaminar structures, with electron dense 
inner and outer KT plates (Fig. 5A) (reviewed in Cleveland et al, 2003). The inner plate 
contains KT proteins implicated in the creation of an interface with centromeric 
chromatin. The outer plate contains KT proteins that interact with MTs. A fibrous corona, 
extending outward from the outer plate, is visible in the absence of MTs and contains 
MT motors, and components of the spindle checkpoint, such as the Rod-ZW10-Zwilch 
(RZZ) complex (reviewed in Santaguida & Musacchio, 2009). A conserved hallmark of 
the centromere–KT interface is a specialized nucleosome containing the histone H3 
variant CENP-A (Blower et al, 2002). Regional centromeres such as those in 
vertebrates contain multiple CENP-A nucleosomes, incorporated at long arrays of 
repetitive DNA sequences (Allshire & Karpen, 2008). Human centromeres form on a 
small subdomain of a highly ordered array containing thousands of copies of a 171-bp 
repeat sequence known as α-I satellite DNA. The α-I satellite DNA contains the CENP-
B box, a sequence recognized by the CENP-B protein (Masumoto et al, 1989). CENP-B 
is required to establish (but not maintain), centromeric chromatin (Okada et al, 2007). 
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Figure 5. Overall organization of the centromere/KT. (A) A mitotic chromosome has been sectioned 
along the plane of the spindle axis, revealing the symmetric bipolar organization of a chromosome fully 
engaged on the spindle. (Right) Key elements have been pseudo colored. Violet, the inner centromere; 
red, the inner KT and yellow, the outer KT. (B) Schematic for the physical map of outer KT of metazoans. 
(C) Non-comprehensive ‘epistatic’ relationships between KT proteins. Arrows indicate a dependency for 
localization. The circles enclosing a ‘P’ indicate post-translational modifications. Illustrations adapted from 
(Cleveland et al, 2003; Santaguida & Musacchio, 2009). 
 
The fact that α-satellite DNA  not strictly required for in centromere specification, 
indicates the existence of epigenetic mechanisms in the establishment and 
maintenance of centromere identity (reviewed in Marshall et al, 2008). CENP-A 
interacts with at least a subset of the subunits of the constitutive centromere-associated 
network complex (CCAN), the major protein assembly at inner KT (Fig. 5B-C) (reviewed 
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in Perpelescu & Fukagawa, 2011). The molecular connection between inner and outer 
KT is unknown, but recent evidence suggests that Cenp-C might fulfill this duty, binding 
both the Cenp-A nucleosome and the major outer KT protein assembly, the KMN 
network (Screpanti et al, 2011). The KMN network has emerged as crucial component 
of the KT machinery involved in generating load-bearing MT-attachment. It is a 
conserved 10-subunit assembly composed of three distinct subcomplexes, known as 
Knl1, Mis12, and Ndc80 (acronym KMN). A growing body of evidence circumstantiates 
the notion that several KMN components establish direct contact with MTs allowing the 
establishment of load bearing attachments that can couple MT depolimerization with 
chromosome movement during anaphase (Cheeseman & Desai, 2008; Santaguida & 
Musacchio, 2009). Interestingly, RNAi mediated depletion of KMN components does not 
only lead to a KT-null phenotype but compromises also the SAC functionality 
(Cheeseman et al, 2004; DeLuca et al, 2005; Martin-Lluesma et al, 2002; McCleland et 
al, 2003; Meraldi et al, 2004). This suggests in turn that the same machinery 
responsible for the establishment for of correct attachment is required for building the 
SAC signaling platform itself.  
Whereas only weak evidence for direct interactions between KMN components 
and the SAC components Mad1/Mad2 has been produced (Kops et al, 2010; Martin-
Lluesma et al, 2002), it is clear that KT recruitment of Mad1/Mad2 depends on the KMN 
network (Fig. 5C) (Martin-Lluesma et al, 2002; McCleland et al, 2003; Meraldi et al, 
2004). Mad1/Mad2 recruitment to KTs is an evolutionarily conserved event that 
intimately correlates with SAC signaling. Moreover, Mis12 is required for KT recruitment 
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Figure 6. Relative movements of mechanical elements within KTs and their impact on SAC 
signaling. (A) High-resolution map of the KT reveals two mechanical arms within the KT (KNL-1 arm and 
Ndc80 arm) that move relative to each other in the presence or absence of MT-mediated intra-KT stretch 
(Control and  Taxol, respectively) (Wan et al, 2009). (B) The geometrical arrangement of the two arms 
could affect SAC signaling by regulating the localization and/or phosphorylation of checkpoint 
components. Illustration adapted from (Maresca & Salmon, 2010). 
 
of one additional metazoan specific ternary complex, called RZZ that is also required for 
Mad1/Mad2 KT recruitment (Kops et al, 2005). These data suggest that the KMN 
network is not sufficient for Mad1/Mad2 binding in higher cells and there is an additional 
requirement for the RZZ complex. In normal circumstances KTs bind either MTs or 
Mad1/Mad2 and the KMN network accounts for both interaction, suggesting a simple 
model in which KMN components bind either MTs or Mad1/Mad2 in a mutually 
exclusive fashion due to steric hindrance (discussed in Burke & Stukenberg, 2008). 
However, recent studies have demonstrated that KT-MT attachment triggers a KT 
structural deformation leading to intra KMN stretch that intimately correlates with SAC 
activation and Mad1/Mad2 KT recruitment (reviewed in Maresca & Salmon, 2010) (Fig. 
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6A). It is therefore likely that the KT (and particularly KMN) structural deformation 
triggers the relative movement of KT-components, possibly moving apart proteins that 
would otherwise contribute to the generation of the Mad1/Mad2 KT receptor (Fig. 6B).  
Finally, recent studies have demonstrated that manipulation of the SAC kinase 
Mps1 at KTs can uncouple KT-MT attachment from the removal of Mad1/Mad2 from 
KTs (Jelluma et al, 2010; Kemmler et al, 2009), challenging therefore the notion of 
mutual exclusivity and suggesting that Mps1 participates in promoting the binding of 
Mad1/Mad2 to KTs by phosphorylating Mad1 itself and/or KMN components (Fig. 6B).   
The anaphase promoting complex or cyclosome, the SAC target	
Cyclin protein abundances vary throughout the cell cycle, determining changes in 
the activity of cyclin dependent kinases (CDKs) and therefore driving the alternation of S 
and M phase. States of low and high CDK activities are imposed by a cullin-RING finger 
E3 ubiquitin ligase, called anaphase promoting complex or cyclosome (APC/C), that 
targets cyclins for 26S proteasomal degradation. The APC/C is composed of 15-17 
subunits, depending on the organism, most of which have been conserved through 
eukaryotic evolution (reviewed in Peters, 2006; Pines, 2011). The APC/C can be 
subdivided into two subcomplexes, one made of the catalytic subunit APC2 
(homologous to cullin) and APC11 (the RING-finger protein), the other one made of 
several proteins containing tetratricopeptide repeats (TPRs) that serve as binding sites 
for establishing protein-protein interactions. The two subcomplexes are held together by 
the largest subunit, APC1 (Fig. 7A). APC/C dependent ubiquitination requires the 
presence of one WD40 repeat containing activator, either Cdc20 or Cdh1. Structural 
and biochemical data suggest that both the APC/C subunit APC10 together with Cdh1 
confer substrate specificity by forming the receptor for one type destruction signals 
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present in substrates (the so called D-boxes) (Buschhorn et al, 2011; da Fonseca et al, 
2011) (Fig. 7A-B). Biochemical evidence supports the notion that Cdc20 binds the 
APC/C to form a D-box degron receptor similarly to Cdh1 (Izawa & Pines, 2011), but 
structural evidence is missing.  
The APC/C is responsible for degradation of a variety of cell cycle regulators that 
has to occur in a tightly controlled fashion (Fig. 7C). Unlike other E3 ligases that 
recognize their substrates only following pre-phosphorylation by regulatory kinases, the 
APC/C recognizes the vast majority of its substrates regardless of their phosphorylation 
status. This implicates that the APC/C activity itself is cell cycle regulated and that its 
substrate specificity changes throughout the cell cycle (Fig. 7C). Before mitotic entry, 
the APC/C is devoid of Cdk1 dependent phosphorylation that is triggered upon NEBD 
(Kraft et al, 2003). Mitotic Cdk1 firing will on one hand promote the association between 
the APC/C and its activator Cdc20 (Kraft et al, 2003; Rudner & Murray, 2000) and on 
the other hand functionally neutralize the other APC/C activator, Cdh1 (Cross, 2003). 
Whereas APC/CCdc20 dependent degradation of Cyclin A (and Nek2a) 
commences upon NEBD, the SAC imposes a delay in the poly-ubiquitination of the 
APC/CCdc20 crucial substrates such as Cyclin B1 and Securin, coupling therefore 
chromosome bi-orientation with anaphase onset (Di Fiore & Pines, 2010; reviewed in 
Pines, 2011). The target of the SAC is Cdc20 and several SAC proteins associates with 
it in a cytoplasmic quaternary complex comprising Cdc20 itself, Mad2, BubR1 and 
Bub3, also called mitotic checkpoint complex (MCC)(Sudakin et al, 2001). Both Mad2 
and BubR1 can bind Cdc20 directly and inhibit the APCCdc20 in vitro (Fang, 2002; Fang 
et al, 1998; Tang et al, 2001), but recent evidence suggests that, upon SAC activation, 
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Mad2 binds Cdc20 first, thereby priming it for subsequent binding of BubR1:Bub3 
(Kulukian et al, 2009; Nilsson et al, 2008). How can the latter complex prevent Cyclin B1 
and Securin degradation is an active field of investigation and two models have been 
recently proposed: BubR1 (or Mad3 in S. cerevisiae) can on one hand act as a 
pseudosubstrate inhibitor of APC/CCdc20 (Burton & Solomon, 2007) and on the other 
hand promote Cdc20 degradative autoubiquitination by the APC/C during SAC 
signaling, reducing therefore the APC/CCdc20 activity towards other substrates (King et 
al, 2007; Nilsson et al, 2008; Pan & Chen, 2004). However, the role of Cdc20 
autoubiquitination is controversial since other studies have proposed that it is required 
for MCC disassembly upon SAC silencing at metaphase (Reddy et al, 2007; Stegmeier 
et al, 2007). Whether these possibilities are mutually exclusive will have to be clarified, 
but recent evidence suggests that different MCC pools (bound and unbound to the 
APC/C) display differential dependencies on proteolysis for their disassembly (Ma & 
Poon, 2011), suggesting that degradative and non degradative ubiquitination might co-
exist in the cell. Degradative ubiquitination of Cdc20 by the APC/C depends on the SAC 
and is crucial for cell cycle arrest. SAC dependent Cdc20 degradation requires the 
APC/C subunit APC15, that is otherwise dispensable for APC/C activity in the absence 
of the checkpoint (Mansfeld et al, 2011).   
How the SAC directs the APC/C activity towards a subset of substrates while 
inhibiting degradation of others is only beginning to emerge. Recent evidence suggests 
that incorporation of Cdc20 into the MCC forces it to associate with a specific APC/C 
subunit during prometaphase (APC8). When the SAC is silenced in metaphase the 
Cdc20 association with the APC/C will also require APC3 (Izawa & Pines, 2011).  
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Figure 7. APC/C structure and function. (A) Schematic of the APC/C subunits. The APC/C can be 
subdivided in two subcomplexes that are connected by a scaffolding subunit (APC1). One subcomplex is 
catalytic and comprises APC2 and APC11 (which recruit the E2). The other subcomplex is composed of 
tetratricopeptide repeat (TPR)-containing proteins (APC3, APC6, APC7 and APC8) and binds substrates, 
APC10 and the co-activator (Cdc20 or Cdh1). APC10 seems to interact with both APC3 and APC2 
(indicated by a dashed line). (B) Structure of the human APC/Cs derived from an electron microscopy 
single particle three-dimensional reconstruction study (Buschhorn et al, 2011). The APC/C appears as a 
pyramidal shape, with a central cavity in which the co-activator, Cdc20 or Cdh1, binds next to the APC10 
subunit to form the destruction box (D box) degron receptor. (C)	 As cells progress through mitosis, 
specific proteins are degraded at distinct time points; these are depicted below the arrow.	 The timing of 
their destruction is determined by their sensitivity to the SAC (Cyclin A vs. Securin and Cyclin B1) and by 
whether they can be recognized before (Cyclin A, Securin and Cyclin B1) or after anaphase (Cdc20, 
UBCH10, Plk1 and Aurora A). Illustrations adapted from (Pines, 2011). 
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The Mad2 template model for SAC signaling and silencing 
While the SAC control of the APC/C substrate specificity awaits structural 
clarification, our understanding of the role of Mad2 in SAC signaling has greatly 
benefited from structural analysis (Luo et al, 2002; Luo et al, 2004; Mapelli et al, 2007; 
Sironi et al, 2002). The Mad2 protein can in fact adopt two distinct natively folded states: 
“Open” (or “N1”) and “Closed” (or “N2”) (O and C-Mad2, respectively). The two 
conformers differ in the orientation of a C-terminal beta-sheet that in the Closed 
conformation surrounds the polypeptide chain of a Mad2-interaction partner (or “ligand”) 
in a structure reminiscent of a safety belt (Sironi et al, 2002) (Fig. 8A). Best-known 
ligands of Closed-Mad2 are Mad1 (a SAC component) and Cdc20 (the SAC target). 
Mad1 is crucial for KT recruitment of Mad2, whereas Cdc20 is a cytoplasmic Mad2 
target upon SAC activation. A prevailing model for SAC signaling, the so-called 
‘template model’, can readily explain how Mad2 can relay a signal from the KT to 
APC/CCdc20 in the cytoplasm. Central to the model is the ability of Mad2 to dimerize 
asymmetrically, i.e. O-Mad2 can bind C-Mad2 (Fig. 8B) (De Antoni et al, 2005; Mapelli 
et al, 2006; Mapelli et al, 2007). Moreover, reconstitution experiments have shown that 
a complex of Mad1:C-Mad2 can, through Mad2 asymmetric dimerization, enhance the 
ability of O-Mad2 to bind Cdc20, thereby generating a structurally equivalent C-
Mad2:Cdc20 complex (De Antoni et al, 2005; Kulukian et al, 2009; Lad et al, 2009; 
Nasmyth, 2005; Vink et al, 2006), utilizing a prion-like mechanism of propagation of the 
closed conformer of Mad2 (Skinner et al, 2008) (Fig. 8C). Some aspects of this template 
model find experimental support also in the cellular environment: Mad1 clearly is the KT 
receptor of Mad2 (Chen et al, 1998; Luo et al, 2002; Martin-Lluesma et al, 2002) and 
interfering with Mad1 affects the ability of Mad2 to bind Cdc20 (Fraschini et al, 2001; 
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Hardwick et al, 2000; Hwang et al, 1998). Furthermore, FRAP experiments performed in 
mammalian cells revealed a biphasic recovery after photobleaching of KT-associated 
Mad2, indicating the existence of two distinct Mad2 populations (Shah et al, 2004). 
While one population showed a slow turnover reminiscent of the recovery kinetics of 
Mad1 (Shah et al, 2004), the other Mad2 population turned over much faster, similar to 
the behavior of Cdc20 at KTs (Howell et al, 2004). The template model has been 
supported by several lines of evidence, but direct experimental proof for its operation 
within cells was lacking. 
Chromosome bi-orientation leads to SAC silencing and this in turn allows 
anaphase onset. While several pathways involved in SAC silencing have been 
described, two are thought to be crucial in mammalian cells. The first is based on the 
dynein dependent “stripping” from KTs of SAC components and other proteins, notably 
Spindly, upon MT attachment (Gassmann et al, 2010; Howell et al, 2001). This pathway 
accounts for the removal of the KT source of SAC signaling, but does not contribute 
directly to the disassembly of cytoplasmic complexes that should be rapidly promoted 
upon SAC inactivation. The second pathway is based on a binding partner of Mad2, 
known as p31comet, which associates selectively with the dimerization interface of C-
Mad2 in vitro, suggesting that p31comet might act as a competitive inhibitor for Mad2 
dimerization (Mapelli et al, 2007; Xia et al, 2004; Yang et al, 2007) (Fig. 8D). Depletion 
of p31comet from cells interferes with efficient recovery from a SAC dependent arrest 
and extends the duration of unperturbed mitosis (delaying the cytoplasmic disassembly 
of the MCC), whereas overexpression of p31comet causes a SAC override (Habu et al, 
2002; Jia et al, 2011; Xia et al, 2004; Yang et al, 2007). Although these data strongly 
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implicate p31comet in SAC silencing, it is unknown how the p31comet:Mad2 interaction 
is regulated in time and space in vivo. 
	
Figure 8. The Mad2 ‘template model’ for SAC signaling. (A) Topology diagram of O-Mad2 and C-
Mad2. In C-Mad2, the two strands β8’–β8’’ are extensions in opposite directions of the β8 strand of O-
Mad2. MBP1 = 12-residue Mad2 binding peptide 1. (B) Ribbon model of the Mad2 conformational dimer 
composed of Mad2LL (loop less, adopting the open conformation) and Mad2wt–MBP1 (C-Mad2 binding 
MBP1) according to the crystal structure of the complex. (C) The Mad2 ‘template model’: encounter of O-
Mad2 with C-Mad2 bound to Mad1 starts the SAC. The Mad1/Mad2 core complex recruits O-Mad2 to 
KTs, and O-Mad2 is converted into C-Mad2 bound to Cdc20. Mad2/Cdc20 is a structural copy of 
Mad1/Mad2 because Mad1 and Cdc20 share a Mad2 binding motif and Mad2 adopts the same C-Mad2 
conformation in these complexes. The C-Mad2/Cdc20 complex dissociates from the Mad1/Mad2 core 
complex. In the cytosol, Mad2/Cdc20 acts as a structural equivalent of Mad1/Mad2 to convert more O-
Mad2 into Cdc20 bound C-Mad2. Signal amplification occurs because Mad2/Cdc20 converts O-Mad2 to 
Cdc20 bound C-Mad2. (D) A surface representation to show that C-Mad2 uses a similar surface for the 
binding of p31comet or O-Mad2. The p31comet-binding residues of C-Mad2 are colored yellow, and the 
four key interacting residues, R133, Q134, R184 and F141, are colored red. The O-Mad2-binding 
residues of C-Mad2 are colored yellow. The same four residues R133, Q134, R184, and F141 (red) that 
are important for p31comet binding are also involved in O-Mad2 binding. Illustrations adapted from (De 
Antoni et al, 2005; Mapelli et al, 2007; Yang et al, 2007).      
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Control of mitotic timing, clock or domino? 
The circumstances in which SAC genes were discovered in S. cerevisiae defined 
their pathway as a genuine checkpoint: a non-essential surveillance mechanism that 
becomes active (and crucial) only upon malfunctions (Hoyt et al, 1991; Li & Murray, 
1991). Later work has shown that the SAC genes are conserved in mammals, clarifying 
that they exert a similar checkpoint function (see for example Jin et al, 1998; Li & 
Benezra, 1996).  Careful live cell imaging combined with antibody microinjection 
showed that functional neutralization of Mad2 and BubR1 in mammalian cells triggers a 
drastic anticipation of anaphase onset when compared to cells traversing mitosis in the 
absence of spindle defects (Gorbsky et al, 1998; Shannon et al, 2002). This suggested 
in turn that the SAC in mammals is more crucial than other checkpoints, as it becomes 
activated every cell cycle and contributes to the timing, and therefore faithful 
chromosome segregation, in all somatic cell divisions. Consistent with this idea, 
homozygous deletions of several SAC genes are embryonic lethal in mice (Dobles et al, 
2000; Iwanaga et al, 2007; Wang et al, 2004). One explanation for the observed 
divergence between the SAC function in yeast and human might be extrinsic to the SAC 
signaling itself but rather depend on differences in KT-MT attachment. In other words, 
unattached KTs that are physiologically arising in every mammalian prometaphase 
might rarely occur in yeast, due to the fact that KT-MT attachment is established prior to 
mitotic entry in this organism. Consistent with this notion, Mad1 and Mad2 localize to 
KTs in every mammalian prometaphase, whereas the same localization is observed 
only upon spindle damage in budding yeast (Gillett et al, 2004). This view also readily 
explains observations made in flies, where KT-MT attachments are achieved very 
rapidly and the SAC is not essential for viability and fertility (Buffin et al, 2007). In this 
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perspective, the SAC remains a genuine checkpoint -or domino- with a sensor, a signal 
transduction cascade and an effector, but with the peculiarity that the ‘defect’ being 
sensed (unattached KTs) arises physiologically every cell cycle in certain organisms. 
This simple view has been challenged by one study that characterized the phenotypes 
of siRNA-mediated depletions of SAC components in human somatic cells (Meraldi et 
al, 2004). This study showed that siRNA of all SAC components tested (Mad1, Mad2, 
Bub3 and BubR1) compromised the ability of the cells to respond to spindle disruption 
by nocodazole, but only depletion of a subset of the same SAC components (Mad2 and 
BubR1), could trigger an acceleration of the traverse of mitosis. Importantly, depletions 
of Mad1 and Bub3 were shown to be sufficient to delocalize Mad2 and BubR1 from 
KTs, respectively, but this was nevertheless not sufficient to trigger the mitotic 
acceleration observed upon Mad2 and BubR1 direct depletion. This prompted Meraldi 
and colleagues to propose that Mad2 and BubR1 control mitotic timing independently of 
their KT localization and therefore the SAC. In this perspective, Mad2 and BubR1 would 
be part, in addtion to their contribution to the SAC, of a timer mechanism -or clock-, that 
acts in the cytoplasm.  
The timer function of Mad2 does not readily find a mechanistic explanation in the 
template model, but the fact that Mad2 could influence the timing of Cyclin B1 
degradation independently of Mad1 suggests that cytoplasmic O-Mad2 can form a C-
Mad2:Cdc20 complex in a non-catalyzed fashion.  
The nuclear envelope and the control of cell division 
During mitosis the cell undergoes major structural rearrangements. Among the 
structures affected, the nuclear envelope (NE) is of special importance as it constitutes 
the defining boundary between the nuclear components and the cytoplasm. The NE can 
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be seen as an extended sheet of the endoplasmic reticulum that covers the chromatin. 
It is formed by two juxtaposed membranes, the outer and inner nuclear membrane. The 
NE surrounds the chromatin but does not form a continuous isolating layer since the 
outer and the inner membrane fuse forming holes that are occupied by large protein 
assemblies, called nuclear pore complexes (NPCs, Fig. 9A). NPCs serve as both 
molecular sieves and transport hubs during interphase. Higher eukaryotes undergoing 
an open mitosis form a cytoplasmic mitotic spindle, which requires NEBD to allow 
access of spindle MTs to KTs. NEBD not only involves the removal of NE membranes, 
but also the disassembly of large protein complexes, such as NPCs and the network of 
intermediate filament that composes the lamina (reviewed in Guttinger et al, 2009). An 
initial event of NEBD is the dispersal of soluble nucleoporins, many of which are 
released from the NE as mitotically stable nucleoporin subcomplexes. NPC disassembly 
occurs within minutes and affects multiple nucleoporins synchronously, with the 
exception of Nup98 that dissociates from NE slightly before other components (Dultz et 
al, 2008). NE disassembly continues with the lamina depolymerization. NPC 
disassembly and lamina depolymerization depend on the activation of mitotic kinases, 
which directly contribute to the phosphorylation of NE proteins, with CDK1 displaying a 
major role in NEBD (Heald & McKeon, 1990; Peter et al, 1991). Furthermore, CDK1 
might also be directly involved in NPC disassembly as many nucleoporins are 
phosphorylated on CDK1 sites during mitosis, but additional kinases are known to 
contribute to NEBD in various species, including protein kinase C (PKC) (Goss et al, 
1994), Aurora A (Hachet et al, 2007; Portier et al, 2007), NIMA-related kinases (Laurell 
et al, 2011) and polo like kinase 1 (PlK1). Particularly, a lack of PlK1 activity delays 
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NEBD in C. elegans and human somatic cells (Chase et al, 2000; Lenart et al, 2007) 
and a phosphoproteomic screen has recently identified several nucleoporins as likely 
Plk1 substrates (Santamaria et al, 2010).  
Although the NE does not exist as a functional unit during mitosis, some of its 
components have key roles in the regulation of different mitotic processes after NEBD. 
Such processes include 1) spindle formation, 2) KT-MT attachment, 3) direct regulation 
of the APC/C and 4) indirect regulation of the APC/C through the SAC (reviewed in 
Guttinger et al, 2009). One nucleoporin that has been implicated in spindle assembly is 
RNA export 1 (RAE1). RAE1 forms a complex with NuP98. In mitosis, RAE1 binds to 
MTs and is required for spindle formation in vitro and in vivo (Blower et al, 2005). In 
addition, RAE1 has been shown to share sequence homology with the SAC protein 
Bub3 and Rae1+/- mice were shown to be unable to arrest in mitosis after the induction 
of spindle damage (Babu et al, 2003).  Furthermore RAE1, in complex with its partner 
NuP98, interacts with a Cdh1-associated fraction of APC/C during prometaphase 
(Jeganathan et al, 2005), possibly playing an additional role in APC/CCdh1 inhibition, 
beside CDK1 direct phosphorylation. Conversely, the NuP107-160 complex has a 
prominent role at KTs, where it promotes stable KT-MT attachment and recruits 
additional nucleoporins.  
Interestingly, the SAC proteins Mad1 and Mad2 localize to the nuclear envelope 
during interphase in various organisms including S. cerevisiae, A. nidulas, D. 
melanogaster and humans, strongly suggesting that this localization pattern has been 
conserved throughout eukaryotic evolution. The recruitment of Mad1/Mad2 to the NE 
depends on direct interactions between Mad1 (and Mad2 in humans) with the 
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nucleoporin Mlp/Megator/Tpr in fungi/flies/humans, respectively (hereafter referred 
exclusively as Tpr) (De Souza et al, 2009; Iouk et al, 2002; Lee et al, 2008; Lince-Faria 
et al, 2009; Scott et al, 2005). Tpr is the architectural element of the nucleoplamic 
basket of NPCs (Krull et al, 2004) (Fig. 9B). Whether the association of Mad1/Mad2 with 
Tpr at NPCs induces a functionally inactivated state of the SAC components has not 
been tested, but it became recently clear that depletion of Tpr compromizes the SAC 
functionality in mitosis of all organisms analyzed (De Souza et al, 2009; Iouk et al, 2002; 
Lee et al, 2008; Lince-Faria et al, 2009; Scott et al, 2005). Whereas biochemical 
approaches showed that the interaction between Mad1/Mad2 and Tpr is maintained 
throughout mitosis, the localization of Tpr to KTs positive for Mad1/Mad2 remains 
controversial for human cells (Lee et al, 2008; Lince-Faria et al, 2009). Therefore, the 
mitotic action of Tpr could be exerted at KTs or in the form of soluble cytoplasmic 
component in human cells (Lee et al, 2008; Lince-Faria et al, 2009), in the context of a 
spindle associated ‘matrix’ in fly cells (Lince-Faria et al, 2009) or at the level of the intact 
NPCs proximal to KTs in fungi undergoing a closed mitosis (De Souza et al, 2009; Iouk 
et al, 2002; Scott et al, 2005). One alternative option that has not yet been emphasized 
in the literature is that Tpr might act during prophase by initiating the SAC at NPCs, 
prior to the re-localization of SAC components to KTs. To this end, the mitotic kinases 
as Mps1 and Plk1 also localize at the NE during prophase (Tighe et al, 2008; A. 
Santamaria, unpublished) and both Tpr and Mad1 are likely to be substrates of both 
kinases (Santamaria et al, 2010; C. von Schubert, A. Baron and A. Santamaria, 
unpublished), suggesting therefore that Tpr might serve as a scaffold at NPCs, 
promoting phosphorylation of SAC components required for their KT function.  
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Figure 9 Structural features of the nuclear envelope and Tpr as architectural element of the NPC 
basket. (A) The inner and outer nuclear membranes (INM and ONM, respectively) are separated by the 
perinuclear space (PNS). The nuclear lamina underlies the nucleoplasmic face of the INM. INM proteins 
link the nuclear envelope (NE) membrane to chromatin and the lamina, whereas ONM proteins provide a 
connection from the nucleus to the cytoskeleton. NPCs are large macromolecular assemblies of 60–120 
MDa that display eight‑ fold rotational symmetry. They are built from ~30 different proteins, termed 
nucleoporins (Nups). Major architectural features of the NPC are cytoplasmic filaments and the nuclear 
basket. Illustration adapted from (Guttinger et al, 2009) (B) Evidence for Tpr constituting the central 
architectural element that forms the scaffold of the nuclear basket: distributions of gold grains relative to 
NPCs after immunogold labeling of different Tpr domains, as displayed in (Krull et al, 2004). 
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Aim 
The Mad2 template model is supported by several lines of evidence, but direct 
experimental proof for its operation within cells was lacking. Although the model is 
central for our current understanding of the SAC signaling and is strongly supported by 
structural data (Luo & Yu, 2008; Mapelli & Musacchio, 2007), the lack of tools to 
discriminate between O-Mad2 and C-Mad2 has so far precluded the analysis of Mad2 
conformation in a cellular context. Furthermore, some observations, particularly the 
purported Mad1-independent function of Mad2 in regulating mitotic timing (Meraldi et al, 
2004), do not readily find a mechanistic explanation in the template model.  
The general aim of this work has been to gather mechanistic insight on the action 
of Mad2 and on its regulation in the cellular context. To this end, we characterized a 
monoclonal antibody (mAb) raised against human Mad2 and demonstrate that it 
specifically recognizes the dimerization interface of the closed conformer of Mad2. This 
afforded a unique opportunity to test the template model in the cellular context. 
Specifically, we asked 1) whether Mad2 adopts two conformations in the cell, the open 
conformation for Mad2 devoid of ligands and the closed conformation when associated 
to those proteins, 2) whether the Mad2 template activity is controlled by the regulated 
‘capping’ of C-Mad2 by p31comet, and 3) whether the conformational dimerization of 
Mad2 is required for SAC signaling. Furthermore, the combined used of mAbs 
recognizing Mad1 and C-Mad2 in microinjection experiments allowed us to test the 
controversial notion that Mad2 controls mitotic timing in the cytoplasm independently of 
Mad1 and the SAC. Finally, we aimed to shed mechanistic light on the action of 
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emerging regulators of Mad1:C-Mad2 activity at KTs, namely the kinases Mps1, Plk1 
and the nucleoporin Tpr.  
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Results 
Generation and characterization of antibodies to Mad1, p31comet and Mad2 
With the aim of better defining the role of Mad1, Mad2 and p31comet in the SAC 
signaling of human cells, several antibodies recognizing specifically these key signaling 
molecules were generated. The availability of these reagents together with their detailed 
characterization reported below resulted in a toolbox for the study of the checkpoint 
signaling and constitutes the foundation of this thesis. 
Mad1 
To generate monoclonal antibodies to human Mad1, full length MBP (Maltose 
Binding Protein)-tagged Mad1 was expressed and purified from E. coli and used for 
immunization (see methods). Screening of positive supernatants of hybridoma clones 
performed by ELISA led to the identification of two clones producing antibodies reacting 
against the antigen, 117-468(-18) and 117-470(-19). The purified antibodies were 
further characterized, leading to a complementary and non-overlapping spectrum of 
functionality throughout the assays tested (Table 1), strongly suggesting that 117-468 
recognizes a conformational epitope, whereas 117-470 recognizes a linear epitope.   
Use of a twelve-mere peptide array encompassing the entire sequence of human Mad1 
 
 
Table 1. Summary of the characterization of the two Mad1 mAbs used throughout this thesis. The 
functionality of each clone is reported in several assays. One clone (117-468) was functional in assays 
that retained the three dimensional structure of the antigen and not functional on assays that 
compromised it, whereas the other clone (117-470) displayed the opposite behavior. 
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failed to reveal reactivity of 117-468 (consistent with its recognition of a conformational 
epitope), whereas 117-470 recognized two partly overlapping peptides, leading to the 
identification of the octamer Mad129-36 as the epitope of this mAb (Fig. 10). 
 
Figure 10. Epitope mapping of 117-470. A total of 178 12-mer peptides encompassing the entire Mad1 
protein sequence (718 amino acids) with a 4 amino acid shift were spotted on nitrocellulose membranes 
in duplicates. Peptide arrays were constructed using standard F-moc chemistry on a MultiPep robotic 
spotter according to the manufacturer’s directions (Intavis). Membranes were analyzed by Western blot 
with 117-468 (A) and 117-470 (B). The reactivity of 117-470 towards two consecutive peptides 
(sequences are reported in the rectangle) highlights the SGLDISTS octamer (residues 29-36 of Mad1) as 
the minimal protein sequence sufficient for mAb recognition. 
 
Mad1 structure comprises an extended coiled coil domain (aa 48-630) 
responsible for homodimerization that is just interrupted by an unstructured loop 
including the Mad2 binding motif (aa 531-549) and a C-terminal domain (aa 631-718) 
that should fold as a stable globular entity according to its resistance to limited 
proteolysis (Iwanaga et al, 2002; Sironi et al, 2002) (Fig. 11A). The conformational 
epitope of 117-468 within Mad1 could therefore arise at the level of the quaternary 
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structure within the coiled coil domain or within the tertiary structure of the C-terminal 
globular domain of the antigen. To discriminate between these possibilities, we 
overexpressed Myc-tagged truncations of Mad1 in HEK293T cells and assessed their 
ability to be immunoprecipitated by 117-468 (Fig. 11B). The results obtained are 
consistent with the notion that 117-468 recognizes a conformational epitope within the 
C-terminal globular domain of Mad1. Importantly, this domain includes determinants 
that are conserved from yeast to human and that are strictly required for Mad1 function 
in budding yeast (Chen et al, 1999; Sironi et al, 2002), consistent with the neutralizing 
power of this mAb in microinjection experiments (Table 1 and see below). 
p31comet 
To generate polyclonal antibodies to human p31comet, His-tagged full length human 
p31comet was expressed and purified from E. coli and used for immunization (see 
methods). Serum obtained from one rabbit (# 741212) was functional in Western blot 
and immunoprecipitation experiments, but could not recognize endogenous p31comet 
in immunofluorescence experiments (Fig. 12 and data not shown). 
Mad2 
To generate monoclonal antibodies to human Mad2, full length GST-tagged Mad1 
was expressed and purified from E. coli and used for immunization (see methods). 
Screening of positive supernatants of hybridoma clones performed by ELISA led to the 
identification of one clone producing antibody reacting with the antigen, 107-276(-3). 
The purified antibody was characterized by immunofluorescence, microinjection, 
immunoprecipitation, Western blot and peptide binding experiments, displaying 
functionality exclusively in assays that retain the three dimensional structure of the 
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antigen (Fig. 13). This strongly suggested that 107-276 recognizes a conformational 
epitope on Mad2. 
 
 
Figure 11. 117-468 recognizes the C-terminal globular domain of Mad1. (A) Schematic 
representation of the Mad1 domain structure. Mad148-630 constitutes a coiled coil domain interrupted 
exclusively in position 531-549 by the unstructured loop including the Mad2 binding motif, whereas 
Mad1631-718 folds as a stable globular domain. Mad1381-400 constitutes a nuclear localization signal (NLS) 
and Mad1485-584 is the minimal region of Mad1 retaining dimerization and Mad2 binding. The 
presence/absence (+/-) of binding to 117-468 as shown in (B) is indicated for each truncation. (B) 
HEK293T cells were transfected with the indicated Myc-tagged  constructs (Myc-O/E for Myc 
overexpression) for 36 h. Cells were lysed and immunoprecipitations (IPs) with Mad1 117-468 mAb were 
performed. Inputs and IPs were analyzed by SDS-PAGE and Western blot with Myc mAb.    
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Figure 13. 107-276 recognizes a conformational epitope. (A) Table summarizing the characterization 
of the Mad2 mAb used throughout this thesis. The functionality of each clone is reported in several 
assays. 107-276 was functional in assays that retained the three dimensional structure of the antigen. (B) 
Scheme of the arrangement of 12-mer peptides on nitrocellulose. A total of 98 12-mer peptides 
encompassing the entire Mad2 sequence (205 amino acids) with 2 amino acid shifts were spotted in an 
ordered array. Peptide arrays were constructed using standard F-moc chemistry on a MultiPep robotic 
spotter according to the manufacturer’s directions (Intavis). A c-Myc peptide (EEQKLISEEDLL) containing 
the epitope of the 9E10 mAb was spotted twice as positive control. The array described was spotted in 
duplicates. (C and D) Western blot on membranes described in (B) were performed with 9E10 or CM2276 
mAb, respectively. 
 
Figure 12. Basic characterization of 
741212, rabbit polyclonal Ab to 
p31comet. (A)  HeLaS3 cells were 
transfected with the indicated siRNA 
oligonucleotides for a total of 48 h, arrested 
with thymidine for 24 h, released for 10 h 
and harvested. Lysates were obtained and 
analyzed by Western blot with p31comet 
and α-tubulin antibodies. (B) IPs were 
performed from asynchronous HeLaS3 cells 
using rabbit unspecific IgGs (as control) and 
p31comet antibody. Input and IPs in were 
analyzed by Western blot using the 
p31comet antibody. 
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Given the fact that Mad2 has two distinct native folded states (Luo et al, 2004), the 
possible selective recognition of the Open or Closed conformer was tested. To this end, 
His-tagged Mad2 was purified from E. coli in either its wild type form (Mad2WT) or as 
mutants (Mad2V193N and Mad2L13Q, respectively) that are known to mimic the two distinct 
conformers, O-Mad2 and C-Mad2 (Mapelli et al, 2007, see also Table 2 for a summary 
of the mutant´s characteristics). In IP, the mAb displayed increased reactivity towards 
C-Mad2 when compared to Mad2WT or O-Mad2 (Fig. 14). These results demonstrate 
that the mAb 107-276 is specific for the Closed conformer of Mad2; therefore, it will 
hereafter be referred to as “CM2276” (Closed Mad2, clone 276). Note that a Mad2 
polyclonal antibody that did not display preference for any Mad2 conformer in Western 
blot experiments (i.e. denaturing conditions, Fig. 14, lower panel) was used for all 
Western blot experiments throughout this thesis.  
One additional monoclonal antibody against Mad2 (also recognizing C-Mad2 and 
named “CM22F12”) was recently generated and its characterization is reported as 
Appendix.  
 
 
Figure 14. 107-276 (CM2276) recognizes 
selectively C-Mad2. Purified Mad2WT (WT), 
Mad2L13Q (Closed) and Mad2V193N (Open) were 
immunoprecipitated (IP) with CM2276. Inputs and 
IPs were analyzed by Coomassie Brilliant Blue 
staining (CBB) and Western blot (WB) using a 
rabbit polyclonal Mad2 antibody. IgG HC and LC 
indicate heavy and light IgG chains, respectively.
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CM2276 recognizes C-Mad2 on the dimerization interface 
A prediction arising from the selective recognition of C-Mad2 by CM2276 is that this 
mAb should be able to co-precipitate the known C-Mad2 interaction partners. Therefore, 
we asked whether the CM2276 can co-precipitate Mad1, Cdc20 and/or p31comet from a 
human cell lysate. Both Mad1 and Cdc20 were enriched in the immune complexes 
obtained after immunoprecipitating C-Mad2 from SAC-arrested HeLaS3 cells, whereas 
p31comet was not (Fig. 15A). Since the interaction of Mad2 with p31comet reportedly 
peaks upon SAC silencing (Xia et al, 2004), we also used CM2276 to immunoprecipitate 
C-Mad2 from a lysate of cells synchronized in metaphase by the proteasome inhibitor 
MG132 and having therefore an extinguished SAC. Again, p31comet was not detected 
in CM2276 immune complexes, although it was present in immunoprecipitates that were 
prepared using a polyclonal Mad2 antibody (Fig. 15B). These results demonstrate that 
CM2276 is unable to co-immunoprecipitate p31comet with Mad2, even though a 
Mad2:p31comet complex is present in metaphase-arrested cells. p31comet is known to  
 
Figure 15. CM2276 can co-immunoprecipitate Mad1 and Cdc20 but not p31comet. (A) 
Immunoprecipitations (IPs) were performed with unspecific IgGs or CM2276 from HeLaS3 lysates obtained 
from cells arrested with nocodazole. (B) IPs were performed from HeLaS3 cells released from 
nocodazole for 2.5 h in the presence of MG132 using rabbit unspecific IgGs (as control) and a rabbit 
Mad2 antibody (IP (rabbit)) or with mouse unspecific IgGs (as control) and CM2276 (IP (mouse)). Input and 
IPs in (A) and (B) were analyzed by Western blot using the indicated antibodies. 
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interact with C-Mad2 through direct contact with the dimerization interface of Mad2 
(Mapelli et al, 2006; Yang et al, 2007). Thus, we asked whether CM2276 competes with 
p31comet for C-Mad2 binding. Specifically, we performed GST-pull down assays, using 
GST-Cdc20111-138 that had been pre-adsorbed on glutathione-sepharose beads (GSH) 
and bound to His-tagged WT-Mad2 (Mad2WT), thereby generating a C-Mad2:GST-
Cdc20111-138 complex (Mapelli et al, 2006). As expected, this complex readily pulled 
down both CM2276 and His-tagged p31comet, provided that the two proteins were 
added separately (Fig. 16A, lanes 1 and 2). In striking contrast, co-incubation of CM2276 
with increasing concentrations of p31comet decreased the amount of CM2276 that was 
bound by C-Mad2 (Fig. 16A, lanes 3-5), clearly demonstrating competition between 
p31comet and CM2276 for binding to C-Mad2. Attesting to the specificity of this 
competition, increasing concentrations of the unrelated protein His-hSpindly1-444 (Chan 
et al, 2009) did not affect the association of CM2276 to C-Mad2 in this assay (Fig. 16B). 
One prediction of the observed competition between p31comet and CM2276 is that the 
antibody should interfere with Mad2 conformational dimerization (Mapelli et al, 2006; 
Mapelli et al, 2007; Yang et al, 2007). Indeed, co-incubation of CM2276 with Mad2∆C, 
known to adopt the Open conformation (Table 2), also resulted in a competitive 
behavior in that CM2276 abolished the ability of Mad2∆C to bind to C-Mad2:GST-
Cdc20111-138 (Fig. 16C, lanes 3-5). In contrast, equal concentrations of a Mad1 mAb did 
not interfere with the binding between Mad2∆C and C-Mad2, demonstrating specificity of 
this competition (Fig. 16D). 
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Figure 16. CM2276 recognizes the dimerization interface of C-Mad2. (A) Purified CM2276, p31comet or 
a mixture of constant amount of Mad2 mAb with increasing concentrations of p31comet were incubated 
with Mad2:GST-Cdc20111-138 complex preadsorbed on GSH beads. Inputs and GST pulldowns were 
analyzed by Coomassie Brilliant Blue staining. (B) Purified CM2276, hSpindly1-444 or a mixture of constant 
amounts of CM2276 with increasing concentrations of hSpindly1-444 were treated as described in (A). (C) 
Purified CM2276, Mad2∆C or a mixture of Mad2∆C with increasing concentrations of CM2276, were treated 
as described in (A). (D) Purified Mad1 mAb (117-468), Mad2∆C, or a mixture of Mad2∆C with increasing 
concentrations of Mad1 mAb were treated as described in (A). Asterisks in (A-D) indicate a contaminant 
of the GST-Cdc20111-138 preparation with electrophoretic mobility similar to the IgG light chain. The arrow 
and the circle in (A-D) mark the species used at constant or increasing concentrations, respectively. (E) 
Purified Mad2∆C was added to Mad2:GST-Cdc20111-138 complex adsorbed on GSH beads, following pre-
incubation with buffer (-) or CM2276 (+). GST pull downs were analyzed by Coomassie Brilliant Blue 
staining. The arrow marks Mad2∆C. (F) Purified Mad2WT (WT) and Mad2RQ (R133E-Q134A) were 
immunoprecipitated with CM2276. Inputs and IPs were analyzed by Coomassie Brilliant Blue staining.  (G) 
Schematic representation of the CM2276 epitope. 
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Binding of Mad2∆C was also prevented upon prior adsorption of CM2276 to C-
Mad2:GST-Cdc20111-138 beads (Fig. 16E). To further demonstrate that CM2276 binds to 
the C-Mad2 dimerization interface, we also tested its ability to recognize a Mad2 protein 
that carries the double mutation R133E-Q134A (Mad2RQ), which is known to affect 
residues crucial for Mad2 dimerization and p31comet binding (De Antoni et al, 2005; 
Yang et al, 2007) (Fig. 16F). As shown in Fig. 10G, Mad2RQ was barely able to bind to 
CM2276 when compared to Mad2WT. The most likely interpretation of these data is that 
CM2276 recognizes a conformational epitope on the dimerization interface of C-Mad2 
and that this epitope is critical for both conformational dimerization and p31comet 
binding (Fig. 16G).   
 
Table 2 summarizes the features of the Mad2 mutants used throughout this thesis. 
 
Only liganded Mad2 adopts the Closed conformation in vivo	
Having established that CM2276 recognizes selectively the Closed conformer of 
Mad2 that represents the “active” specie according to the “Mad2 template model” (De 
Antoni et al, 2005) afforded a unique opportunity for testing the prediction of the model 
in the cellular context. The template model predicts not only that Mad2 adopts two 
distinct conformations in the cell, Open and Closed, but also that O-Mad2 should freely 
diffuse in the cytoplasm and, by definition, be devoid of ligand, whereas C-Mad2 should 
tightly bind Mad1 and therefore be a resident component of unattached KTs. 
Furthermore, during SAC signaling the Mad1:C-Mad2 complex is predicted to exert a 
catalytic function by triggering the conversion (through asymmetric dimerization) of O-
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Mad2 to C-Mad2 (with Cdc20 as ligand). Although this model is appealing and strongly 
supported by structural data (Luo & Yu, 2008; Mapelli & Musacchio, 2007), the lack of 
tools to discriminate between Open and Closed Mad2 has so far precluded the analysis 
of Mad2 conformation in a cellular context. To monitor the two state behavior of Mad2 in 
cells, we fractionated cell lysates by size exclusion chromatography (SEC) and 
analyzed each fraction for the presence of C-Mad2, using CM2276 for IP (Fig. 17A). In 
order to analyze transitions between interphase and mitosis as well as cells with both an 
active and an inactive SAC, we synchronized HeLaS3 cells in G1/S phase, 
prometaphase and metaphase (by addition of thymidine, nocodazole and MG132, 
respectively; Fig. 17B). The use of a Superdex 200 column resulted in a Mad2 elution 
profile that showed two peaks of comparable intensity; these reflect Mad2 associated 
with its interaction partners (>440 kDa) and monomeric Mad2 (ca. 25 kDa), respectively 
(Fig. 17C, “TCAP” panels; see also Experimental Procedures). CM2276 IP on all 
fractions invariably revealed the ability of this mAb to recognize Mad2 bound to its 
interaction partners, but not free Mad2 (Fig. 17C, “CM2276 IP” panels). These data 
confirm that Mad2 adopts the Closed conformation when in complex with other proteins. 
Moreover, they indicate that free Mad2 adopts the Open conformation at all cell cycle 
stages examined.   Theoretically, one could argue that the free Mad2 could actually be 
in the closed conformation but not be recognized by CM2276, due to epitope masking by 
p31comet. However, this is clearly not the case as p31comet did not extensively co-
migrate with free Mad2 (Fig. 17D). We also note that the elution profile of p31comet did 
not show major changes during the different cell cycle stages analyzed (Fig. 17D). The 
absence of 
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Figure 17. (A) Distribution of C-Mad2 among “free” and “bound” pools of the protein. (A) 
Schematic representation of the approach followed to study the distribution of C-Mad2. Synchronized 
HeLaS3 cells were lysed and fractionated by size exclusion chromatography (SEC). SEC was performed 
with a Superdex 200 16/60 column, followed by collection of 4 ml fractions through the 120 ml of elution 
volume. Fourteen fractions covering size ranges from the upper limit of the column to 13.7 kDa were 
further processed in parallel by TCA precipitation (TCAP) and CM2276 IP. Resulting samples were 
analyzed by Western blot. (B) Timeline of the synchronization used for experiments shown in (C-E); 
“MG132” cells were first arrested in thymidine for 24 h and were incubated in the presence of nocodazole 
for 12 h after release, collected by mitotic shake off and released for 2.5 h in the presence of MG132. 
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“Thymidine” and “Nocodazole” cells were harvested following thymidine and nocodazole block, 
respectively. (C-F) Western blots on samples obtained from TCA precipitations (TCAP) and CM2276 IP on 
fractions obtained as described in (A), following synchronization as described in (B). Western blots were 
performed with rabbit Mad2 polyclonal antibody (C), p31comet antibody (D), Mad1 mAb (E) and Cdc20 
antibody (F). (G) Schematic summary of the results displayed in (C-F). 
 
p31comet in the CM2276 IPs is readily explained by antibody-competition for the 
p31comet binding site (see Fig. 16A and 7G) but it is more difficult to explain the 
absence of p31comet in the high molecular weight fractions of total cell lysates, 
especially in MG132 treated cells where we could clearly highlight the presence of a 
Mad2:p31comet complex (Fig. 15B). We interpret this to indicate that only a very minor 
fraction of the total cellular p31comet interacts with Mad1:C-Mad2 complexes at any 
given stage. In support of this conclusion, semi-quantitation of cellular protein levels 
indicates that p31comet is approximately twice as abundant as total Mad2 (Fig. 18).  
Western blots for the other known Mad2 ligands revealed that Mad1 co-migrated 
with C-Mad2 and could be co-immunoprecipitated by CM2276 throughout the cell cycle 
(Fig. 17E). In stark contrast, Cdc20 migrated as a monomeric species in interphase and 
did not display any interaction with C-Mad2 (Fig. 17F, upper panels), arguing against 
the existence of a sizeable pool of MCC during interphase. During SAC activation 
Cdc20 shifted to the higher molecular weight fractions, where it clearly interacted with 
C-Mad2 (Fig. 17F, middle panels). Upon SAC silencing, however, the bulk of Cdc20 
was again released as a monomeric entity and only a minor population, still engaged in 
protein complexes, could be co-immunoprecipitated by CM2276 (Fig. 17F, lower panels). 
Interestingly, the association of C-Mad2 with Cdc20 during prometaphase was not 
reflected in a major change in the overall elution profile of total Mad2 (Fig. 17C), 
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consistent with the emerging notion that the inhibitory action of Mad2 on Cdc20 is likely 
to be catalytic rather than stoichiometric (Kulukian et al, 2009; Nilsson et al, 2008). 
 
Figure 18. Estimate of Mad2 and p31comet protein abundances. 50 µg of an asynchronous HeLaS3 
total cell lysate together with the indicated number of nanograms (ng) of recombinant 6His-Mad2 or 6His-
p31comet (upper and lower panel, respectively), have been analyzed by SDS-PAGE and Western blot 
with the indicated antibodies. Bands corresponding to the recombinant and endogenous (endo) protein 
are indicated. Densitometry analysis of the bands was used to estimate the amount of endogenous 
protein loaded (estimate are shown below each gel). 
 
Analytical fractionation of SAC components performed by size exclusion 
chromatography previously employing a Superose 6 matrix (Nilsson et al, 2008; 
Sudakin et al, 2001) could resolve different Mad2 subcomplexes, namely free-Mad2, 
Mad2 incorporated into the MCC complex (together with Cdc20 and BubR1:Bub3) and a 
Mad2 containing MCC that associates to the APC/C. Indeed, a similar experiment 
performed with a Superose 6 column also revealed the presence of Mad2 in both the 
MCC and the APC/C+MCC complexes (Fig. 19A). Downstream immunoprecipitation 
highlighted that Mad2 adopts the close conformation both in the MCC and APC/C+MCC 
fractions (Fig. 19B). Collectively, our results show that liganded Mad2 (i.e. bound to 
either Mad1 or Cdc20) adopts the Closed conformation in human cells, whereas free 
Mad2 remains in the Open conformation during the cell cycle.  
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Mad1 is required for the formation of C-Mad2 in interphase 
Our data show that, within cells, Mad1 is a constitutive ligand of C-Mad2, whereas 
Cdc20 is entrapped into Mad2´s safety belt only during checkpoint activation (Fig. 17 
and 10). As C-Mad2 is the energetically favored conformer in vitro (Luo et al, 2004), we 
asked whether Mad2 can possibly adopt the Closed conformation in vivo, in the 
absence of any known ligand. To this end, we used siRNA to deplete Mad1 from 
interphase-arrested cells, in which Mad1 is the only established ligand of C-Mad2, 
before samples were analyzed using the assay described above. When compared to 
the Gl2 control, Mad1 siRNA caused a significant (albeit not complete) reduction in 
Mad1 protein levels (Fig. 20A-B and E). Under these conditions, a marked shift of Mad2  
Figure 19. Resolution of C-Mad2 
containing subcomplexes. (A) A cell 
lysate obtained after synchronization with 
nocodazole (as in Fig. 17) was fractionated 
by (SEC) on a Superose 6 10/300 GL 
column. TCA precipitates obtained from 
each fraction were analyzed by Western 
blot with the indicated antibodies. Three 
pools (APC/C+MCC, MCC and free-Mad2) 
of 5 fractions each were further analyzed by 
CM2276 IP (B) or IP using a Mad2 rabbit Ab.  
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Figure 20. Requirement of Mad1 for C-Mad2 formation in interphase. (A) SEC analysis performed 
with a Superdex 200 16/60 column of a lysate obtained from HeLaS3 cells treated with Gl2 siRNA for 60 
h and arrested with thymidine for 24 h. Samples were concentrated by TCA precipitation (TCAP). 
Western blots were performed with the indicated antibodies. (B) Samples obtained as in (A) but following 
Mad1 siRNA-mediated depletion. (C, D) Samples obtained by CM2276 IP against the same fractions used 
in (A) and (B), respectively. Western blots were performed with indicated antibodies. (E) Fractions 
highlighted as large and small in (A-D) were pooled and Western blots were performed with the indicated 
antibodies.  (F) Schematic representation of the Mad2 sub-complexes found in interphase: Mad2 is either 
bound to Mad1, adopting the Closed conformation or free, adopting the Open conformation. (G) In the 
absence of Mad1, Mad2 cannot adopt the Closed conformation during interphase, and the bulk is thereby 
released as Open free Mad2.  
 
from the liganded population to the free population was observed (Fig. 20A-B and E), 
confirming that Mad1 is the major binding partner of Mad2 in interphase cells. 
Importantly, while CM2276 was able to immunoprecipitate the Mad1:C-Mad2: complex, 
but not free Mad2, from Gl2 control cells (Fig. 20C-E), the amount of C-Mad2 that could 
be precipitated by CM2276 from Mad1-depleted cells was decreased in proportion to the 
reduction in Mad1 levels, without a corresponding increase of free Mad2 in the CM2276 
IP (Fig. 20D-E). These data clearly demonstrate that the association with Mad1 is 
required for interphase Mad2 to adopt the Closed conformation; furthermore, they 
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suggest that, in vivo, C-Mad2 does not accumulate to significant levels in the absence 
of ligand (Fig. 20F-G). 
The Mad1:C-Mad2 complex is required to initiate the SAC 
The key prediction made by the template model is that C-Mad2 is required for the 
catalytic activation of a cytosolic pool of O-Mad2 and that this conversion is in turn 
indispensable for SAC signaling. The ability of CM2276 to interfere with Mad2 
conformational dimerization afforded a unique opportunity to test this model within the 
cellular context. In a series of experiments, monoclonal antibodies were microinjected 
into HeLaS3 stably expressing histone H2B-GFP and progression through mitosis was 
monitored by time  lapse video microscopy. We first asked whether C-Mad2 is required 
to initiate SAC signaling. To this end, cells were injected in interphase and treated with 
nocodazole before progress through mitosis was monitored (Fig. 21A). As expected, the 
microinjection of a Myc mAb, used as negative control, did not interfere with the ability 
of HeLaS3 cells to respond to nocodazole, as all injected cells underwent mitotic arrest 
for at least 6 hours without signs of apoptosis (Fig. 21B-C). In stark contrast, the 
majority of the CM2276 injected cells escaped the nocodazole block in less than 1 hour, 
resulting in cells with decondensed chromatin and aberrantly shaped nuclei, a 
phenotype typical of SAC override (Fig. 21B-C). Importantly, the microinjection 
phenotype caused by CM2276 injection depended exclusively on C-Mad2 recognition, as 
coinjection of the antibody with Mad2L13Q but not Mad2V193N (mimicking C-and O-Mad2, 
respectively), abolished the observed phenotype (Fig. 22).  
Having established that Mad1 is required for the formation of C-Mad2 in 
interphase, microinjection of cells with a neutralizing Mad1 antibody should lead to a  
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Figure 21. C-Mad2 is required for initiating and maintaining a SAC-dependent arrest. (A) Schematic 
representation of the microinjection protocol followed to assess the ability of cells to respond to 
nocodazole upon CM2276 injection. Interphase HeLaS3 stably expressing histone H2B-GFP cells were 
subjected to microinjection 7 h after thymidine release and analyzed by time lapse video microscopy in 
the presence of nocodazole. (B) Movie stills from representative cells injected with the indicated mAbs. 
Time in h:min is indicated. T=0 was defined as the time point at which nuclear envelope breakdown 
(NEBD) became evident. Scale bars = 10 µm. (C) Histogram showing cells microinjected with the 
indicated mAbs, subdivided into the displayed categories according to the time elapsed between nuclear 
envelope breakdown (NEBD) and nocodazole override (SAC override). Percentage of cells is shown (n = 
total number of cells counted).  
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Figure 22. The microinjection phenotype of CM2276 depends on reactivity towards C- but not O-
Mad2. (A) Interphase HeLaS3 stably expressing histone H2B-GFP cells were subjected to microinjection 
7 h after thymidine release and analyzed by time lapse video microscopy in the presence of nocodazole. 
Microinjection was performed with CM2276 co-injected with PBS only (CM2276 + PBS), 6His-Mad2V193N 
(CM2276 + O-Mad2) or Mad2L13Q (CM2276 + C-Mad2), utilizing a molar 1:2 ratio of antibody:recombinant 
Mad2. Movie stills from representative cells injected with the indicated mAbs. Time in h:min is indicated. 
T=0 was defined as the time point at which nuclear envelope breakdown (NEBD) became evident. Scale 
bar = 10 µm. (B) Histogram showing cells microinjected with the indicated mAbs, subdivided into the 
displayed categories according to the time elapsed between NEBD and nocodazole override (SAC 
override). Percentage of cells is shown (n = 21 cells per condition). 
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similar override. Indeed, Mad1 mAb injection (117-468), resulted in a nearly identical 
phenotype (Fig. 21B-C). These results strongly indicate that the conformational 
dimerization of Mad2 at the level of the Mad1:C-Mad2 complex is required for SAC 
signaling, as predicted by the template model and supported by experiments conducted 
in budding yeast (Nezi et al, 2006). 
The Mad1:C-Mad2 complex is required to maintain the SAC 
Next, we asked whether Mad2 conformational dimerization is also required to 
maintain an already established SAC arrest. This question was of particular interest, as 
several lines of recent evidence indicate that Mad2 acts epistatically upstream of 
BubR1/Mad3 (Burton & Solomon, 2007; Hardwick et al, 2000; King et al, 2007; Kulukian 
et al, 2009; Nilsson et al, 2008). To examine this issue, we injected CM2276 into mitotic 
HeLaS3 cells in which the SAC had been activated by treatment with nocodazole and 
analyzed the injected cells 20, 40 and 60 minutes later by fluorescence microscopy (Fig. 
21A). Already 20 minutes after CM2276 injection, levels of Cyclin B1 were decreased to 
background levels in approximately half of the cells, and by 60 minutes all injected cells 
had overcome the nocodazole-induced arrest (Fig. 21B-C), while injection of Myc mAb 
for control did not trigger a SAC override, as expected (Fig. 21B-C). We have also 
analyzed the kinetics of SAC override in response to microinjection of the anti-Mad1 
mAb. This antibody triggered an even faster SAC override than CM2276 (Fig. 21B-C). 
These results demonstrate, first, that C-Mad2 (and hence conformational dimerization) 
is required to maintain an already established SAC-dependent arrest, supporting and 
extending previous data obtained with a polyclonal Mad2 antibody (Gorbsky et al, 
1998).  
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Figure 23. The Mad1:C-Mad2 complex is required for maintaining a SAC dependent arrest. (A) 
Schematic representation of the protocol followed to assess the capability of cells to maintain an already 
established SAC-dependent arrest upon microinjection of CM2276 and Mad1 mAb.  Asynchronous 
HeLaS3 cells were treated with nocodazole for 5 h and mitotic cells were selectively microinjected with 
the mAbs. After injection, cells were incubated for 20, 40 or 60 min in the presence of nocodazole and 
fixed with PTEMF. Cyclin B1 was stained with a mAb directly coupled to Alexa Fluor 488. (B) 
Representative cells treated as described in (A). Cyclin B1 (green), DNA was visualized with DAPI (blue) 
and the injection marker Texas Red dextran (red) are displayed. Scale bar = 10 µm. (C) Histogram 
showing cells microinjected with the indicated mAbs, subdivided into the displayed categories according 
to the absence (-) or presence (+) of Cyclin B1 staining. Percentage of cells is indicated (n = total number 
of cells counted). The microinjection procedure was established and performed by Manuel Kaulich. 
 
Our data do not contradict an important role for BubR1 in APC/CCdc20 inhibition, 
but demonstrate a continuous requirement for C-Mad2 for sustaining this inhibition. 
Second, they also bear on a model of SAC signaling that invokes a contribution of an 
autocatalytic loop based on cytosolic C-Mad2 (De Antoni et al, 2005). Specifically, our 
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side-by-side comparison of the consequences of anti-Mad1 mAb and CM2276 injection 
argues that cytosolic C-Mad2 alone cannot provide sufficient C-Mad2:Cdc20 to maintain 
a SAC arrest.  
The Mad1:C-Mad2 complex is required to regulate mitotic timing 
In addition to being an essential component of the SAC, Mad2 has been 
proposed to constitute a key component of a mitotic timer operating in the cytosol 
(Meraldi et al, 2004). In support of this notion, the siRNA-mediated knockdown of Mad2 
and BubR1 caused not only SAC silencing but also a striking acceleration of mitotic 
progression, whereas the knockdown of other Mad or Bub components was reported to 
abolish the SAC without accelerating the traverse of mitosis (Meraldi et al, 2004). A 
mechanistic understanding of the proposed KT-independent mitotic timer is presently 
elusive, but the fact that Mad1 was reportedly dispensable (Meraldi et al, 2004) 
suggested the non-catalytic generation of a C-Mad2:Cdc20 complex. To clarify the 
relationship between the proposed Mad2-dependent mitotic timer and the SAC in 
human cells, we took advantage of CM2276 and asked whether interfering with 
conformational dimerization (and therefore C-Mad2 catalysis) would cause a similar 
mitotic acceleration, as the generalized Mad2 knockdown. We injected interphase 
HeLaS3 stably expressing histone H2B-GFP with either CM2276 or Myc mAb, as control, 
and analyzed their progression through an unperturbed mitosis by time-lapse video 
microscopy (Figure 24A). Injection of Myc mAb (or buffer alone) caused a noticeable 
delay in the elapsed time between nuclear envelope breakdown (NEBD) and anaphase 
onset (54±8.1 and 69±6.1 min in average ± s.d., respectively), when compared with 
control non-injected cells (41.7±3.7 min) (Figure 24B and C), most likely reflecting the 
cellular stress caused by the microinjection procedure. More importantly, injection of 
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CM2276 led to a drastic mitotic acceleration (22.4±1.5 min) (Figure 24B and C); in 
addition, CM2276-injected cells invariably showed signs of chromosome missegregation, 
indicative of SAC abrogation (i.e. chromosome bridges and/or lagging chromosomes) 
(Figure 24B). These results clearly show that conformational dimerization of Mad2 is 
also involved in regulating mitotic timing. From the perspective of the proposed timer 
model, allegedly dependent on Mad2 but not Mad1, the above results create a 
conundrum. They imply that either C-Mad2 can be generated in a Mad1-independent 
manner or, alternatively, Mad1 is also part of the mitotic timer mechanism. To 
distinguish between these possibilities, we used the Mad1 mAb, which was able to 
neutralize the SAC (Figure 21), to carry out microinjection experiments. Remarkably, 
microinjection of this anti-Mad1 mAb led to a striking acceleration of unperturbed mitosis 
(19.1 ± 1.2 min), causing also a strong chromosome missegregation phenotype (Figure 
24B and C), similar to the results obtained when injecting CM2276. This indicates that 
Mad1 also contributes to mitotic timing regulation. 
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Figure 24. The Mad1:C-Mad2 complex is required 
for regulating mitotic timing. (A) Schematic 
representation of the microinjection protocol followed to 
analyze the progression through an unperturbed 
mitosis after mAb microinjection. Interphase HelaS3 
stably expressing histone H2B-GFP cells were 
subjected to microinjection 7 h after thymidine release 
and analyzed by time lapse video microscopy. (B) 
Movie stills from representative cells injected with the 
indicated mAbs as described in (A). Control cells 
correspond to non-injected cells. Time in h:min is 
indicated. T=0 was defined as the time point at which 
NEBD became evident. Scale bar = 10 µm. (C) Box-
and-whisker plot showing the elapsed time (min) 
between NEBD and anaphase onset for individual cells 
microinjected as described in (A). Analysis performed 
on > 40 cells per condition, from 3 independent 
experiments. Lower and upper whiskers in (C) 
represent 10th and 90th percentiles, respectively. 
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The SAC regulates mitotic timing operating intra-mitotically and not through a 
pre-assembled inhibitor 
When the “timer model” has been originally proposed, it has been postulated that 
a timer mechanism would be necessary to keep the APC/C activity in check during 
prophase, while KTs are still assembling and are not yet fully mature and capable to 
generate a “wait anaphase” signal (Meraldi et al, 2004). In addition, a recent study 
proposed that the MCC assembles in the cytoplasm pre-mitotically in an Mps1-
dependent manner, suggesting therefore that the MCC formed prior to mitosis 
corresponds to the “timer” (Maciejowski et al, 2010). In order to address to which extent 
the regulation of mitotic timing relies on the formation of an APC/C inhibitor during 
interphase, we undertook two different but complementary approaches. First, antibodies 
were microinjected into cells that had been arrested at the G2/M boundary with the 
Cdk1 inhibitor RO-3306 (Vassilev et al, 2006), and mitotic progression was then 
monitored following inhibitor wash out (Fig. 25A). The injection of either CM2276 or the 
anti-Mad1 mAb caused a striking mitotic acceleration (NEBD-to-anaphase onset; 24.4 
and 22.3 min on average, respectively) when compared with non-injected cells (68.5 
min on average) (Fig. 25B-C). These data show that the pre-mitotic contribution of both 
C-Mad2 and Mad1 to mitotic timing regulation is minor if not absent. Second, we took 
advantage of the fact that the SAC kinase Mps1, required for Mad1:C-Mad2 loading to 
KTs, is amenable to chemical inhibition and has also been recently implicated in the 
regulation of mitotic timing (Hewitt et al, 2010; Maciejowski et al, 2010; Santaguida et al, 
2010; Sliedrecht et al, 2010). Specifically, we monitored the timing of mitotic 
progression in cells that experienced an Mps1 inhibition already during S, G2 and M 
phase or only during M phase (Fig. 26A). Remarkably, Mps1 inhibition led to an 
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indistinguishable mitotic acceleration, regardless of the timing of inhibitor addition (Fig. 
26B-C). These results lend no support to the idea that Mps1 affects the duration of 
mitosis acting independently of the SAC. Furthermore it did not escape our notice that 
first, we failed to observe a sizeable MCC during interphase (Fig. 17) and second,  
 
Figure 25. The Mad1:C-Mad2 complex controls mitotic timing acting after mitotic entry. (A) 
Schematic representation of the protocol followed to analyze the progression through mitosis when mAbs 
were microinjected at the G2/M boundary. HeLa Kyoto H2B-mCherry cells were microinjected after 
addition of RO-3306 for 20 h and mitotic progression was followed by time lapse video microscopy 
following RO-3306 release. Only cells that displayed nuclear envelope breakdown (NEBD) within 20 min 
after RO-3306 release were further analyzed. (B) Box-and-whisker plot showing the elapsed time (min) 
between NEBD and anaphase onset for individual cells microinjected as described in (A). Analysis 
performed on ≥ 10 cells. Lower and upper whiskers in (B) represent 10th and 90th percentiles, 
respectively. (C) Movie stills from representative cells injected with the indicated mAbs as described in 
(A). Control cells correspond to non-injected cells. Time in h:min is indicated. T=0 was defined as the time 
point at which NEBD became evident whereas the first still displayed corresponds to the first time point of 
the movie, concomitant to RO-3306 release. Scale bar = 10 µm. 
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Figure 26. Mps1 control of mitotic timing (A) Schematic representation of the protocol followed to 
analyze the progression of cells through mitosis after Mps1 inhibition. HeLaS3 cells stably expressing 
histone H2B-GFP were synchronized by double thymidine arrest-release and their mitotic progression 
was monitored by time lapse video microscopy. Cells were either dividing in the absence of Mps1-IN1 
(Control), following addition of Mps1-IN1 concomitant to the second thymidine release (pre-M Mps1-IN1) 
or with the addition of Mps1-IN1 concomitant to chromosome condensation (intra-M Mps1-IN1). (B) Movie 
stills from representative cells treated as described in (A). Time in h:min is indicated. T=0 was defined as 
the time point at which NEBD became evident and the time point of the addition of Mps1-IN1is indicated. 
(C) Box-and-whisker plot showing the elapsed time (min) between NEBD and anaphase onset for 
individual cells treated as described in (A). Twenty cells per condition were counted. Lower and upper 
whiskers in (C and D) represent 10th and 90th percentiles, respectively. 
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multiple KTs became Mad1:C-Mad2 positive before completion of nuclear envelope 
breakdown (see below). Taken together, the above data identify the KT Mad1:C-Mad2 
complex as a prominent regulator of mitotic timing in human cells and they call for a 
reconsideration of the distinction between SAC and mitotic timer in human cells. 
The Mad1:C-Mad2 complex undergoes p31comet dependent “capping” 
Mad1 is known to form a constitutive protein complex with Mad2 throughout the cell 
cycle (Campbell et al, 2001; Chen et al, 1998; De Antoni et al, 2005). The two proteins 
also display identical localizations. They decorate the nucleoplasmic side of the nuclear 
pore complex (NPC) during interphase (Campbell et al, 2001) and then relocalize to 
KTs upon mitotic entry. Upon KT-MT attachment, they are “stripped” from KTs in a 
dynein and MT-dependent manner and transiently accumulate at spindle poles 
(Gorbsky et al, 1998; Howell et al, 2001; Li & Benezra, 1996). Here we used our newly 
generated mAbs to study the subcellular localization of Mad1 and the Closed conformer 
of Mad2. The known localization patterns were seen when endogenous Mad1 was 
stained with a mAb in HeLaS3 cells (Fig. 27A). However, contrary to expectation, co-
staining of the same cells with CM2276 revealed only partial co-localization with Mad1. 
Although CM2276 staining revealed clear KT localization from prophase to 
prometaphase, C-Mad2 could barely be detected by this antibody at NPCs and spindle 
poles (Fig. 27A). 
p31comet dependent capping of C-Mad2 at NPCs and spindle poles 
One possible explanation for this result is that Mad2 adopts the Open 
conformation at NPCs and spindle poles. Alternatively, one or more proteins might 
mask the dimerization interface of C-Mad2 at NPCs and spindle poles. As p31comet 
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localizes to both NPCs (Tighe et al, 2008; A. Musacchio, personal communication) and 
the mitotic spindle (Habu et al, 2002) and we have previously demonstrated that  
 
 
Figure 27. Subcellular localization of C-Mad2. (A) HeLaS3 cells arrested with thymidine for 24 h were 
released for 10 h and fixed with PTEMF. After fixation, C-Mad2 was stained with CM2276, followed by 
secondary antibody incubation (red). After extensive washing, Mad1 was co-stained with a Mad1 mAb 
directly coupled to Alexa Fluor 488 (green), DNA was visualized with DAPI (blue). White arrows indicate 
spindle pole staining. (B) Cells were transfected with the indicated siRNA oligonucleotides for a total of 48 
h, and synchronized as described in (A). Lysates were obtained and analyzed by Western blot with the 
indicated antibodies. (C and D) Cells transfected with the indicated siRNA oligonucleotides as in (B) were 
treated as described in (A). Scale bars = 10 µm. 
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Figure 28. Localization of LAPGFP-mouse-Mad2 upon p31comet siRNA (A) HeLaS3 and NIH3T3 cells 
were treated for 5 h with nocodazole and fixed with PTEMF. CM2276 antibody (red) and CREST serum 
(blue) incubations were followed by secondary antibody staining. After extensive washing, Mad1 was co-
stained with Mad1 mAb (117-468) directly coupled to Alexa Fluor 488 (green), showing that whereas the 
Mad1 mAb cannot recognize mouse Mad1, CM2276 readily recognizes the mouse orthologue of Mad2.  (B 
and C) HeLa Kyoto cells stably expressing LAPGFP-mouse-Mad2 were transfected with the indicated 
siRNA oligonucleotides for a total of 48 h and synchronized as described in Figure 27. C-Mad2 was 
stained by CM2276 and subsequent secondary antibody incubation (red), Mad1 was directly coupled to 
Alexa Fluor 488 (blue) and LAPGFP-mouse-Mad2 was visualized by direct GFP fluorescence (green). It is 
intriguing that depletion of p31comet resulted in an approximate doubling of GFP fluorescence selectively 
at KTs (but not at NPCs or spindle poles). This suggests that uncapping of C-Mad2 resulted in the 
selective recruitment of O-Mad2 only at KTs, hinting at a level of regulation of Mad2 heterodimer 
formation that is not presently understood. Scale bars = 10 µm. 
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p31comet can mask the CM2276 epitope (Figure 16), we asked whether depletion of 
p31comet could restore the ability of CM2276 to detect Mad2 at NPCs and spindle poles. 
Indeed, depletion of p31comet by two independent siRNA oligonucleotides readily 
allowed the detection of C-Mad2 by CM2276 at both NPCs and spindle poles (Fig. 27C-
D, respectively; for efficiency of p31comet depletion see Fig. 27B). To substantiate this 
conclusion, we also used a HeLa cell line expressing LAPGFP-mouse-Mad2 (Hubner et 
al, 2010; Poser et al, 2008), which allowed us to study the localization of Mad2 through 
the monitoring of GFP fluorescence. As predicted, GFP-fluorescence at the nuclear 
envelope and at spindle pole staining was indistinguishable, regardless of the presence 
or absence of p31comet (Fig. 28A-C).  
p31comet dependent capping of C-Mad2 at KTs 
Most interestingly, we also observed that p31comet depletion caused a 
detectable increase in CM2276 signal at KTs, without affecting the level of resident 
Mad1:C-Mad2 complex (Fig. 29A). Quantification (Fig. 29B) indicates that p31comet 
masks approximately 50 % of C-Mad2 at KTs. Furthermore, a significant increase in 
GFP signal at KTs could be observed in the cell line expressing LAPGFP-mouse-Mad2 
(Fig. 29C), suggesting that additional Mad2, almost certainly in the open conformation, 
had been recruited upon depletion of p31comet. Taken together, these data indicate 
that Mad2 can adopt the Closed conformation at multiple sub-cellular sites, but that the 
dimerization interface of Mad2 undergoes masking by p31comet at NPCs, spindle poles 
and, partially, also at KTs. The data also indicate that unmasking of C-Mad2 leads to 
recruitment of O-Mad2 selectively at KTs, implying that asymmetric dimer formation is 
differentially regulated at KTs, NPCs and spindle poles. 
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Figure 29. p31comet masks C-Mad2 at KTs. Box-and-whisker plots showing the average pixel 
intensities at single KTs expressed as the Mad1/CREST fluorescence ratio in (A), the CM2276/Mad1 ratio 
in (B) and the LAPGFP-mouse-Mad2 (LAP-mMad2)/Mad1 ratio in (C) either in Gl2 or p31comet-1 siRNA-
treated cells. a.u. = arbitrary units, n ≥ 80 KTs from four independent cells for (A) and (B) and n ≥ 180 
KTs from eight independent cells for (C). Lower and upper whiskers represent 10th and 90th percentiles, 
respectively.  
 
p31comet localizes at KTs during an active SAC in a C-Mad2 dependent manner 
The observation that a sizeable population of KT-associated C-Mad2 could be 
unmasked by depletion of p31comet predicts that p31comet associates with KTs 
already during prometaphase, when the SAC is active, and that this KT-association 
should depend on C-Mad2. To explore this point, we expressed Myc-p31comet in its 
wild type form or as a version carrying two point mutations (Q83A-F191A, abbreviated 
as p31cometQAFA) that are known to abolish binding to C-Mad2 (Yang et al, 2007). 
Importantly, the use of a SV40 promoter allowed us to express p31comet at sub-
endogenous levels (Fig. 30A). Following cytosolic pre-extraction, Myc-p31cometWT, but 
not Myc-p31cometQAFA, was readily visualized at C-Mad2 positive KTs (Fig. 30B). In 
addition, depletion of endogenous Mad2 by siRNA completely prevented Myc-
p31cometWT to localize to KTs (Fig. 30C). Taken together, these data show that 
p31comet can localize at KTs during an active SAC and that the Mad1:C-Mad2 complex 
acts as its main KT receptor.  
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Figure 30. p31comet localizes at KTs in a Mad2 dependent manner. (A) HeLaS3 cells were 
transfected with the indicated SV40-Myc expression vectors for a total of 36 h. 12 h after transfection cells 
were arrested with thymidine for 14 h and subsequently released for 10 h. Lysates were obtained and 
analyzed by Western blot with the indicated antibodies. Bands corresponding to endogenous and 
ectopically expressed p31comet are indicated (“endo-p31comet” and “Myc-p31comet”, respectively). (B) 
Cells transfected with the indicated expression vectors were treated as described in (A). CM2276 and 
rabbit-Myc antibodies were detected by secondary antibody staining (red and green, respectively) 
whereas the Mad1 mAb was directly coupled to Alexa Fluor 647 (displayed in blue). (C) Cells transfected 
with either Gl2 or Mad2 siRNA for a total of 48 h were subsequently transfected with the SV40-Myc-
p31cometWT construct, synchronized and treated as described in (B). Scale bars = 10 µm.  
	
A role for Mps1 kinase activity in regulating p31comet dependent capping 
siRNA mediated depletion of Mps1 had revealed its role in recruiting the Mad1:C-
Mad2 complex (Martin-Lluesma et al, 2002), but additional layers of regulation could be 
only uncovered by the discovery of small molecule inhibitors of the kinase: whereas 
inhibition of Mps1 prior and during mitotic entry phenocopied the siRNA mediated 
depletion of the kinase (Hewitt et al, 2010; Kwiatkowski et al, 2010; Sliedrecht et al, 
2010), a distinct function of Mps1 in promoting the Mad1:C-Mad2 template activity could 
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only be appreciated only when Mps1 is inhibited during mitosis (Hewitt et al, 2010). The 
data reported by Hewitt and colleagues are consistent with the notion that Mps1 
promotes both the localization and the activity of the Mad1:C-Mad2 complex, but when 
the SAC signaling is initiated, Mps1 kinase activity is dispensable for the maintenance 
of Mad1:C-Mad2 at KTs but required for its sustained activity. To gather mechanistic 
insight into this regulation, we used CM2276 to assess whether the dimerization interface 
of C-Mad2 undergoes p31comet-dependent capping upon intra-mitotic inhibition of 
Mps1. To this end, we synchronized cells by the simultaneous addition of nocodazole 
and MG132 (arresting cells either before mitotic entry or in prometaphase) and then 
inhibited Mps1 either with Reversine (Santaguida et al, 2010) or with Mps1-IN1 
(Kwiatkowski et al, 2010)(Fig. 31A). Both inhibitors triggered a Mad1 de-localization 
from KTs, albeit not complete (Fig. 31B-C). One possible explanation is that Mps1 
activity is not completely dispensable for the maintenance of Mad1:C-Mad2 during SAC 
signaling, in contrast to what had been previously reported (Hewitt et al, 2010). 
However, we noticed that the intra-mitotic Mps1 inhibition in a RPE-1 cell line 
expressing an analogue sensitive version of Mps1 (RPE-1-Mps1as) (Maciejowski et al, 
2010) had a comparably minor impact on Mad1 KT maintenance (Conrad von Schubert, 
unpublished). This suggests that the observed differences might be explained by 
different genetic backgrounds and/or by the direct or indirect inhibition of Aurora B 
kinase activity by Reversine and Mps1-IN1 (Kwiatkowski et al, 2010; Santaguida et al, 
2010), that is absent in RPE-1 cells expressing analogue sensitive Mps1(Maciejowski et 
al, 2010). 
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Figure 31 Mps1 regulates the availability of the C-Mad2 dimerization interface at KTs in a 
p31comet-dependent manner. (A) Schematic of the synchronization procedure used to assess the 
impact of Mps1 intra-mitotic inhibition on Mad1 and C-Mad2 detection at KTs. Briefly, nocodazole and 
MG132 were added at the same time for 1 h and followed by addition of Mps1 inhibitor (+) or DMSO (-) 
for one additional hour, followed by PTEMF fixation. (B) After fixation following either Gl2 or p31comet 
siRNA performed for 48h, CM2276 and CREST primary antibody incubation were performed, followed by 
secondary antibody incubation (displayed in red and green). After extensive washing, Mad1 was co-
stained with a Mad1 mAb directly coupled to Alexa Fluor 488 (displayed in blue), DNA was visualized with 
DAPI. Scale bar = 10 µm. (C) Box-and-whisker plots showing the average pixel intensities at single KTs 
expressed as the Mad1/CREST fluorescence ratio (left panel) or the CM2276/Mad1 ratio (right panel), in 
both Gl2 or p31comet siRNA. n > 90 KTs from five independent cells. Lower and upper whiskers 
represent 10th and 90th percentiles, respectively.  
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Regardless of the effects of Mps1 intra-mitotic inhibition on Mad1 KT localization, 
fluorescence reflecting C-Mad2 detection by CM2276 decreased more sharply than the 
Mad1 florescence, in HeLaS3 treated with either Reversine or Mps1-IN1 (Fig. 31B-C) 
and in RPE1-Mps1as cells treated with 3MB-PP1 (Conrad von Schubert, unpublished). 
These data indicate that Mps1 intra-mitotic inhibition leads to a reduction of the 
availability of the dimerization interface of Mad2. siRNA-mediated p31comet depletion 
led to a reversal of this phenomenon (Fig. 31B-C). This indicates that Mps1 kinase 
activity regulates the availability of C-Mad2 dimerization interface through a p31comet 
dependent mechanism. Intriguingly, p31comet has been also identified as a direct 
substrate of Mps1 in vitro assays (A. Musacchio, personal communication), suggesting 
that Mps1 might phosphorylate p31comet at KTs, therefore negatively regulating its 
interaction with C-Mad2. 
A possible role for Tpr in regulating p31comet dependent capping 
Several recent reports identified the nucleoporin Tpr as a conserved regulator of 
the SAC and interacting partner of Mad1/Mad2 (De Souza et al, 2009; Lee et al, 2008; 
Lince-Faria et al, 2009). Whereas there is consensus on the fact that Tpr directly 
interacts with both Mad1 and Mad2 at the NPCs during interphase and on the effects of 
its depletion leading to a SAC deficiency, its mechanistic action in SAC signaling 
remains elusive. According to Lee and colleagues (Lee et al, 2008), Tpr acts as a 
chaperon to promote binding of Mad2 to Mad1 at both the NPCs and KTs, but the 
presence of Tpr at KTs during prometaphase is questioned by Lince-Fraria and 
colleagues (Lince-Faria et al, 2009). We also failed to detect Tpr at KTs using two 
different antibodies that could detect Tpr during interphase at NPCs (data not shown). 
Although both studies have reported the absence of Mad2 from KTs following Tpr 
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depletion, the impact on Mad1 KT recruitment remains controversial. To rule out this 
controversy, we used our Mad1 and CM2276 antibodies to assess the effect of Tpr 
depletion on Mad1:C-Mad2 KT detection. Prometaphase cells that had been treated 
with Tpr RNAi for 72h displayed a normal recruitment of Mad1 to KTs, whereas C-Mad2 
appeared nearly undetectable in the majority of the cells (Fig. 32).  
 
 
Figure 32 Tpr siRNA triggers a selective loss of C-Mad2 staining from KTs. HeLaS3 cells were 
transfected with the indicated siRNA oligonucleotides for a total of 72 h. Cells have been arrested with 
thymidine for 24 h were released for 10 h prior to PTEMF fixation. After fixation, C-Mad2 was stained with 
CM2276, followed by secondary antibody incubation (red). Following extensive washing, Mad1 was co-
stained with a Mad1 mAb directly coupled to Alexa Fluor 488 (green), DNA was visualized with DAPI 
(blue). Scale bar = 10 µm. 
 
In order to assess whether the absence of C-Mad2 detection depended on 
p31comet, which would be consistent with an increased masking by the latter protein, 
we included in our analysis Tpr + p31comet depleted cells. As shown above, the single 
p31comet depletion doubled the fluorescence intensity of CM2276 at KTs (Fig 33A-C). 
Interestingly, the depletion of p31comet performed on the Tpr siRNA background 
restored the levels of C-Mad2 fluorescence intensity to levels intermediate to those 
displayed by control and single p31comet depleted cells (Fig 33A-C) (i.e.  
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Figure 33 (A) Tpr controls the availability of the dimerization interface of C-Mad2 through 
p31comet. Schematic of the synchronization protocol employed to perform single and double depletions 
of p31comet (that could be depleted for maximally 48 h) and Tpr (that required a minimal depletion time 
of 72 h). (B) After fixation of HeLaS3 cells, C-Mad2 was stained with CM2276, followed by secondary 
antibody incubation (red). After extensive washing, Mad1 was co-stained with a Mad1 mAb directly 
coupled to Alexa Fluor 488 (green), DNA was visualized with DAPI (blue). Scale bar = 10 µm. (C) Box-
and-whisker plots showing the average pixel intensities at single KTs expressed as the Mad1/CREST 
fluorescence ratio (left panel) or the CM2276/Mad1 ratio (right panel), in Gl2, p31comet, Tpr and p31comet 
+ Tpr siRNA. n > 80 KTs from four independent cells. Lower and upper whiskers represent 10th and 90th 
percentiles, respectively. (D) Model describing the regulation of the availability of the C-Mad2 dimerization 
interface at KTs being regulated by Tpr through p31comet. 
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significantly higher than those observed in the single Tpr depletion), suggesting that Tpr 
positively sustains the SAC signaling in prometaphase by promoting the unmasking of 
the dimerization interface of C-Mad2 (Fig. 33D). 
Since the increased masking of the dimerization interface at KTs observed upon Tpr 
depletion depended on p31comet, this raised the possibility that the described SAC 
regulation via Tpr depends on p31comet. In order to address this, we assessed the 
SAC functionality by monitoring the mitotic timing of HeLaS3 cells (stably expressing 
histone H2B-GFP) following single and double depletions as before. To this end we 
asked, first, whether the observed mitotic delay upon p31comet siRNA depended on 
Mad2, as proposed by others but never directly tested (Habu et al, 2002; Reddy et al, 
2007; Vink et al, 2006; Xia et al, 2004). As expected, siRNA-mediated depletion of 
p31comet caused a metaphase arrest that depended on Mad2. This shows that the 
p31comet depletion phenotype depends on an hyperactivation of the SAC (almost 
certainly C-Mad2 itself) and not on a direct inhibition of the APC/C (Fig. 34A-C). 
Second, we analyzed the effect of the single Tpr depletion and in combination with 
p31comet: Tpr depletion alone resulted in a penetrant acceleration of the traverse of 
mitosis (Fig. 34D-F), consistent with the notion that Tpr is required to sustain the SAC 
(De Souza et al, 2009; Lee et al, 2008; Lince-Faria et al, 2009). The p31comet and Tpr 
co-depletion resulted in a mitotic timing that was significantly slower than the one 
observed upon single Tpr depletion and that resembled the timing observed in control 
cells (Fig. 34D-F). This observation is consistent with the notion that the removal of 
p31comet dependent masking of C-Mad2 at KTs observed in Tpr depleted cells (Fig. 
33), is sufficient to restore a nearly physiological mitotic timing.   
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One of the caveats of extrapolating functional conclusions from double depletion 
experiments based on the siRNA technology is that different RNA duplexes have 
different potencies and their use in combination may results in competition phenomena, 
possibly through saturation of the RISC complex (Koller et al, 2006). We decided 
therefore to test whether the depletion efficiency of duplexes used in double siRNA 
transfections retained the efficiency displayed when used singly by Western blot. When 
Mad2 and p31comet were co-depleted, the p31comet depletion appeared unaffected by 
the presence/absence of the Mad2 siRNA (Fig. 35A), whereas Mad2 depletion 
efficiency was decreased in the absence of p31comet (Fig. 35A). This phenomenon 
could nevertheless be neglected in the functional analysis (Fig. 34A-C), as the reduction 
of Mad2 levels in the double depletion was sufficient to trigger the same mitotic 
acceleration observed in the single Mad2 depletion. This is consistent with the notion 
that even a minor reduction of Mad2 levels is sufficient to trigger a striking mitotic 
acceleration (Hubner et al, 2010).  
When Tpr and p31comet were co-depleted, the depletion observed for each protein 
in single transfection experiments was retained (Fig. 35B). Surprisingly, Mad2 levels 
appeared downregulated in both Tpr and Tpr + p31comet depletions (Fig. 35B), 
indicating that this Tpr duplex leads to an unexpected Mad2 downregulation. Other Tpr 
siRNA duplexes led to a similar downregulation (data not shown) and the quantitation of 
Mad2 mRNA following Tpr siRNA suggested that the downregulation depends on 
altered protein stability rather than on a Mad2 mRNA reduction (H. Maiato, personal 
communication). This observation majorly complicates the interpretation of the 
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functional regulation of the SAC by Tpr through p31comet and it is discussed more in 
detail below (see Discussion). 
 
Figure 34 Tpr controls mitotic timing in a p31comet-dependent manner. (A) HelaS3 stably 
expressing histone H2B-GFP cells were transfected with the indicated siRNA duplexes for 48 h, treated 
with thymidine for 24h and analyzed by time lapse video microscopy 9 h after thymidine release. Box-
and-whisker plot showing the elapsed time (min) between NEBD and anaphase onset/cell death for 
individual cells. Thirty cells per condition were counted. Mitotic cell death occurred exclusively in the 
p31comet siRNA sample in 6/30 cells. (B) The same dataset displayed in (A) appears plotted using a 
logarithmic scale. (C) Epistatic relationship between p31comet, Mad2 and the APC/C according to (B-C). 
(D) HelaS3 stably expressing histone H2B-GFP cells were transfected with the indicated siRNA duplexes 
and synchronized according to Fig. 33A. Nine hours following thymidine release they were analyzed by 
time lapse video microscopy. Box-and-whisker plot showing the elapsed time (min) between NEBD and 
anaphase onset/cell death for individual cells. Thirty cells per condition were counted. Mitotic cell death 
occurred exclusively in the p31comet siRNA sample in 4/30 cells. (E) The same dataset displayed in (D) 
appears plotted using a logarithmic scale. (F) Epistatic relationship between Tpr, p31comet and Mad2 
according to (D-E). Lower and upper whiskers in (A-B and D-E) represent 10th and 90th percentiles, 
respectively. 
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Figure 35 Efficiencies of p31comet, Mad2 and Tpr single and double depletions. (A) HeLaS3 cells 
were transfected with the indicated siRNA oligonucleotides for a total of 48 h and synchronized as for Fig. 
34A-C. Lysates were obtained and analyzed by Western blot with the indicated antibodies. (B) HeLaS3 
cells were transfected with the indicated siRNA oligonucleotides for a maximum of 72 h and synchronized 
as for Fig. 34D-F, i.e. following the protocol shown in Fig. 33A. Lysates were obtained and analyzed by 
Western blot with the indicated antibodies. 
	
Analysis of the post-translational modifications and interaction partners of 
Mad1:C-Mad2 
Given the availability of a monoclonal antibody that is capable of recognizing 
selectively C-Mad2, we set out to look for interacting partners of Mad2 and specifically 
of its closed conformer in an unbiased approach. To this end, we immunoprecipitated C-
Mad2 from cells arrested in prometaphase by the addition of nocodazole and resolved 
the immune complexes by SDS-PAGE. All the Coomassie stained bands that were 
specifically appearing in the CM2276 IP and that were absent in the IgG pre-cleared of 
the cell lysate were analyzed by triptic digestion followed by LC-MS/MS based peptide 
identification. In addition to Mad2 itself, Mad1 was found enriched in the immune 
complexes to a nearly 1:1 stoichiometric ratio (Fig. 36A). Additional proteins identified 
included the mitotic checkpoint complex (MCC) components BubR1 and Bub3. Cdc20 
itself was not identified in this MS analysis due to the fact that the protein co-migrated  
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Figure 36 Interacting partners and phosphorylation sites of Mad1:C-Mad2. (A) Coomassie Brilliant 
Blue (CBB) staining of mouse unspecific IgGs (mIgG) and CM2276 immunoprecipites resolved on a 4–
12% NuPAGE gel. About 15 mg mitotic HeLa S3 cell lysate was precleared by mIgGs followed by CM2276 
IP. The indicated bands were excised, triptic in-gel digestion was performed followed by LC-MS/MS 
based identification. The first Mascot hit for each band is indicated. (B) Schematic showing Mad1 
phosphorylation sites identified by mass spectrometry. (C) ClustalW alignment of residues 485-495 of 
human Mad1 and the orthologs of the indicated organisms. The “P” circled in yellow indicates the position 
of the identified phospho-site (pS490). (D) The relative phosphorylation levels, as identified by SILAC 
labeling and mass spectrometry, comparing Metaphase (nocodazole) with Prometaphase (MG132), both 
synchronizations performed as described in Fig. 17B or monopolar prometaphases -(TAL)/+(Monastrol) 
Plk1 activity.  
 
with the antibody heavy chain and the corresponding band was not analyzed. Not 
surprisingly, these established interacting partners of Mad2 could be co-precipitated by 
CM2276 due to the fact that they were either ligands of C-Mad2 (Mad1 and Cdc20) or 
interacting partners of C-Mad2 through Cdc20 (BubR1 and Bub3). In addition, the 
mitotic kinesin-like protein 2 Mklp2  (Neef et al, 2003) was also found enriched in the 
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immune complexes. A recent study by Lee and co-workers has also described Mklp2 as 
an interacting partner of Mad2 and biochemical analyses described in the study are also 
consistent with the notion that Mklp2 interacts specifically with the closed conformer of 
Mad2 upon SAC activation (Lee et al, 2010). The two remaining gel slices analyzed by 
LC-MS/MS in the region between 50 and 75 kDa of the SDS-PAGE separation led to 
the identification of peptides of BubR1. Interestingly, BubR1 has been identified as a 
caspase substrate upon apoptosis (Kim et al, 2005; Mahrus et al, 2008). Our data is 
therefore consistent with the notion that a population of the cell sample used in this 
experiment was undergoing apoptosis at the harvest time (a possible consequence of 
the nocodazole arrest) and that BubR1 incorporated in the MCC underwent caspase-
dependent cleavage. In solution digest of CM2276 immunoprecipitates obtained in the 
same conditions led to the identification of one peptide of the 270 kDa protein Tpr (data 
not shown). As C-Mad2 binds to its ligands with strong affinity, further evidence would 
be required to support the notion that Tpr is a novel C-Mad2 ligand, but our data are 
consistent with the notion that Tpr can, directly or indirectly, bind the closed conformer 
of Mad2 in a dynamic fashion.  
Since Mad2 has been described as phosphoprotein (Wassmann et al, 2003), we 
performed phosphopeptide enrichment on triptic digests of CM2276 eluates in order to 
address whether the closed conformer of Mad2 undergoes phosphorylation. Despite 
repeated attempts, we failed to identify phosphopeptides of Mad2 in interphase, 
prometaphase and metaphase samples (synchronized as shown in Fig. 17B, data not 
shown). In support of this, recent work suggested that the phosphorylation of Mad2 
stabilizes the open conformation (Kim et al, 2010). In striking contrast, Mad1 enriched in 
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CM2276 eluates appeared heavily phosphorylated, with 13 phosphorylation sites being 
identified (Fig 36 B). Several of them clustered, in either the N-terminus or in the region 
comprised within 485-584 (Fig. 36B). Since these two regions are required for Mad1 
KT-localization and Mad2 binding, respectively (Chung & Chen, 2002; Sironi et al, 
2002), it is likely that Mad1 phosphorylation plays a crucial regulatory function. Mad1 
has been described as an Mps1 substrate in yeast, where its phosphorylation correlates 
with SAC activation, suggesting that Mad1 is a key Mps1 substrate for SAC functionality 
(Hardwick et al, 1996). The fact that human Mps1 can phosphorylate Mad1 in vitro 
(Santaguida et al, 2010) and that Mps1 activity is required for Mad1 KT localization 
(Martin-Lluesma et al, 2002) suggests that Mad1 is a conserved substrate for Mps1 
kinase, but a thorough analysis of a potential regulation of Mad1 by direct Mps1 
phosphorylation is missing. In addition, Mad1 has been proposed to be a substrate of 
Plk1 (Chi et al, 2008; Santamaria et al, 2010) and both Mps1 and Plk1 kinases 
displayed a similar consensus for the target motif (Dou et al, 2011). In order to pinpoint 
the more relevant phosphorylation sites for Mad1 regulation, we performed a 
comparison of the phosphorylation site occupancy between prometaphase and 
metaphase. Among the sites identified, pS490 appeared to be strongly downregulated 
upon SAC silencing, displaying less than 25% of the occupancy observed in 
prometaphase (Fig. 36D). Importantly, this conserved phosphorylation site (Fig. 36C) 
required Plk1 activity to become phosphorylated, since S490 occupancy decreased to 
less than 20% in Plk1 inhibited samples (through the use of the small molecule inhibitor 
of Plk1 TAL (Santamaria et al, 2007)) when compared to samples were Eg5 was 
inhibited (through the use of monastrol (Mayer et al, 1999)) (Fig. 36D). These and other 
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data (Santamaria et al, 2010 and Santamaria, unpublished) are consistent with the 
notion that S490 undergoes SAC dependent phosphorylation by Plk1 and justified the 
generation of a phospho-specific antibody recognizing Mad1-pS490.  
One serum appeared to recognize preferentially Mad1 when phosphorylated, 
both in WB and immunofluorescence (Fig. 37). S490 could be phosphorylated by Plk1 
directly (Fig. 37A) and, consistent with our mass spectrometric analyses, Mad1 
appeared phosphorylated at S490 during SAC activation (Fig. 37B-C). Interestingly, 
Mad1 appeared non-phosphorylated in interphase cells, it became phosphorylated at 
S490 at the NPCs concomitant with chromosome condensation in early prophase cells 
and remained phosphorylated till prometaphase while localizing at KTs (Fig. 37C). The 
inhibition of Plk1 in the above stages did not lead to a major Mad1 de-localization, but 
drastically reduced the phosphorylation of S490 (Fig. 37D). Our data are consistent with 
the notion that Mad1 undergoes direct phosphorylation by Plk1 at S490 at NPCs upon 
mitotic entry and this modification is maintained upon Mad1 re-localization at KTs during 
prometaphase. In metaphase, upon SAC silencing, S490 undergoes marked de-
phosphorylation, indicating that this phosphorylation event correlates with SAC 
activation. At first glance, the fact that a drastic reduction of Mad1 phosphoryaltion by 
inhibition of Plk1 did not abolish the SAC functionality suggests that pS490 
phosphorylation is dispensable for the SAC. It should nevertheless be noticed that only 
trace amounts of active Mad1 can support the SAC (see above) and that pS490 could 
potentially be phosphorylated -to a much lesser but yet sufficient extent- by residual 
Plk1 and/or Mps1 activity in TAL treated cells. To this end, similar analyses inhibiting 
Mps1 intra-mitotically (i.e. preserving Mad1 KT localization), revealed that Mps1 is also 
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required for in vivo phosphorylation of Mad1-S490 (Anna Baron, data not shown), 
suggesting Mad1 might be phosphorylated by both kinases on the same residue. Future 
work will have to strengthen this notion and to better define the relationship between 
Mps1 and Plk1 in KT SAC signaling.     
 
Figure 37 Direct phosphorylation of Mad1-S490 by Plk1 upon SAC activation. (A) In vitro 
phosphorylation of recombinant MBP-Mad1 in either kinase buffer alone, or by recombinant Plk1 for the 
indicated times with/without the Plk1 inhibitor TAL. The upper panel shows Coomassie Brilliant Blue 
staining (CBB) staining of the SDS-PAGE gel, the central panel shows the corresponding 
autoradiography and the lower panel shows WB analysis using pS490 antibody. The two arrows indicate 
the position of full length MBP-Mad1 and a degradation product for each panel. (B) HeLaS3 cells were 
arrested with nocodalole for 12 h and the obtained lysates were treated with either buffer alone or with the 
indicated recombinant phosphatases. Lysates were analyzed by WB with the indicated antibodies. (C) 
HeLaS3 cells arrested with thymidine for 24 h were released for 10 h in the presence of Monastrol and 
fixed with PTEMF. After fixation, Mad1, Mad1-pS490 and CREST were stained by primary and antibodies 
(green, red and blue, respectively), followed by secondary antibodies displayed in the indicated colors. 
(D) HeLaS3 cells were treated as described in (C) using both Monastrol and TAL. Scale bars = 10 µM. 
Experiments in B-D were performed by Anna Baron.  
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Discussion 
In this thesis we have used a conformation-specific mAb (CM2276) to study 
mechanistic aspects of SAC signaling in living human cells. We demonstrate that 
CM2276 selectively recognizes one of the two Mad2 conformers, namely Closed-Mad2. 
This powerful tool provided a unique opportunity to probe Mad2 conformation and 
directly validate several aspects of the template model for SAC signaling in a cellular 
context. In particular the CM2276 antibody allowed us to demonstrate that Mad1 is 
required for the generation of C-Mad2 in vivo, being therefore necessary for initiating 
and maintaining the SAC, thus providing strong support for the template model. We also 
demonstrate that mitotic timing depends on the Mad1:C-Mad2 template. This latter 
observation suggests that, from a mechanistic perspective, the SAC and the proposed 
mitotic timer are closely related if not identical. The CM2276 antibody allowed us also to 
reveal a role for p31comet in capping C-Mad2 at particular subcellular locations and to 
implicate Mps1 and Tpr in the regulation of this process.  
The two state behavior of Mad2 in the cell 
The template model of SAC signaling hinges crucially on the existence and 
interconversion of two conformers of Mad2 (Luo & Yu, 2008; Mapelli & Musacchio, 
2007). Using CM2276 we have been able to directly visualize the proposed two state 
behavior of Mad2 within living cells. The fact that the C-Mad2 mAb could only 
immunoprecipitate Mad2 when bound to interaction partners strongly supports the 
concept that liganded but not free Mad2 adopts the Closed conformation and our data 
indicate that this conclusion holds true throughout the cell cycle. Importantly, structural 
analysis of Mad2 in complex with its ligands had been carried out using full length Mad2 
bound to rather short truncations of either Mad1 or Cdc20 (99 out of 718 and 39 or less 
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out of 499 amino acids, respectively (Luo et al, 2000; Luo et al, 2002; Sironi et al, 2002). 
Importantly, later work has suggested that the binding of Mad2 to full length Cdc20 
might differ concerning the affinity, dynamics and therefore binding mode (Kulukian et 
al, 2009; Nilsson et al, 2008). Our work supports the notion that the closed conformer of 
Mad2 -as it can be produced in in vitro reconstitutions- binds to its ligands Mad1 and 
Cdc20 in living human cells.  
Concerning the equilibrium between the two conformers of free Mad2, most of 
Mad2 was released as a free moiety when Mad1 was depleted, and this free Mad2 
existed in the Open conformation (as it was not recognized by CM2276). Our data 
demonstrate that Mad1 is strictly required for Mad2 to adopt the Closed conformation in 
vivo. Previous work had already suggested that free Mad2 adopts the Open 
conformation in cells (Luo et al, 2004), and this important notion had been incorporated 
in the template model (De Antoni et al, 2005). However, a recent in vitro reconstitution 
study has also suggested that Mad1:C-Mad2 is able to generate unliganded C-Mad2, 
which then binds Cdc20 with higher efficiency than O-Mad2 (Yang et al, 2008). In our 
study, we did not detect significant levels of unliganded C-Mad2, suggesting that, in 
vivo, the life-time of this species must be short, if it exists at all. As C-Mad2 is the 
energetically favored conformer in vitro (Luo et al, 2004), this raises the question of why 
is C-Mad2 not accumulating as unliganded entity in the cell. Such an accumulation 
could, in the absence of a compensatory masking of the C-Mad2 dimerization interface, 
trigger the unscheduled activation of C-Mad2 dependent catalysis, which would be 
probably sufficient to promote unscheduled binding of Cdc20. Consistent with this 
notion, the microinjection of recombinant Mad2-L13Q (locked in the closed 
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conformation) triggered a metaphase arrest that was absent upon microinjection of 
Mad2-V193N (locked in the open conformation). Also, the p31comet depletion by siRNA 
was sufficient to trigger association of C-Mad2 with Cdc20 in thymidine (G1-S) arrested 
cells (data not shown). Our data support therefore the notion that the amounts of free C-
Mad2 in the cell should be tightly controlled and raise the possibility that in the 
cytoplasm of living cells an as yet unknown mechanism actively promotes the Open 
conformation of unliganded Mad2. Interestingly, Mad2 is reportedly a phosphoprotein 
(Wassmann et al, 2003) and its phosphorylation affects equilibrium between the two 
conformers, stabilizing O-Mad2 (Kim et al, 2010). Mad2 phosphorylation might therefore 
represent one mechanism involved in the stabilization of free Mad2 in the open 
conformation.   
Mad1:C-Mad2 initiating and maintaining the SAC 
Several predictions of the template model find strong support in the 
microinjection experiments carried out in this thesis. The injection of CM2276 abolished 
SAC activation, thus confirming the template model’s prediction that pinpoints the 
dimerization interface as the active site of C-Mad2 catalysis (De Antoni et al, 2005; 
Kulukian et al, 2009; Lad et al, 2009; Simonetta et al, 2009). One interesting emerging 
view is that the C-Mad2:Cdc20 complex generated at KTs is not the final inhibitory 
component of the SAC, but that C-Mad2 acts catalytically - rather than stoichiometrically 
- to promote Cdc20 binding to BubR1 (Kulukian et al, 2009; Nilsson et al, 2008). From 
this perspective, it is interesting that interference with the Mad1:C-Mad2 KT template by 
injection of CM2276 into cells in which the BubR1:Cdc20 complex was already functional, 
also caused an abrupt extinction of the SAC. This indicates that the continuous 
production of new C-Mad2:Cdc20 is required for maintaining a SAC-dependent arrest, 
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even after BubR1 had been loaded onto Cdc20. This in turn suggests that Mad2 is 
required for SAC maintenance by exerting a BubR1-independent inhibitory action on 
Cdc20 and/or by continuously replenishing an intrinsically unstable BubR1:Cdc20 
complex (Burton & Solomon, 2007; King et al, 2007; Nilsson et al, 2008).  
One interesting hypothesis in the SAC field is that cytoplasmic C-Mad2:Cdc20 
can promote its own formation through an autocatalytic loop (De Antoni et al, 2005). 
This idea finds experimental support through in vitro experiments (Lad et al, 2009; 
Simonetta et al, 2009), but the in vivo contribution of a cytosolic branch of Mad2 
template activity remains to be tested. From this perspective, it is interesting that 
microinjection (into nocodazole arrested cells) of an anti-Mad1 mAb (targeting 
exclusively the Mad1:C-Mad2 complex) was at least as efficient in causing a SAC 
override as injection of CM2276 (targeting both KT-associated Mad1:C-Mad2 and 
cytosolic C-Mad2:Cdc20 complexes). Although these quantitative differences may well 
reflect a difference in the function-neutralizing potency of the injected antibodies, our 
observation clearly argues that a C-Mad2:Cdc20 autocatalytic loop is not in itself 
sufficient to maintain a SAC arrest. Interestingly, an in silico model of the SAC that 
accounts for key features of it and is based on measured biophysical parameters, 
excluded the possibility of a cytoplasmic amplification of the cell cycle inhibitor through 
an autocatalytic loop, as the activity of the inhibitor would become self-sustained and 
therefore impossible to be extinguished (see  Ciliberto & Shah, 2009 for review; Doncic 
et al, 2005).  
KT-dependent control of mitotic timing 
Careful live cell studies in siRNA-treated human cells have led to the proposal 
that anaphase onset depends on a mitotic timer that involves Mad2 and BubR1, but not 
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Mad1 (Meraldi et al., 2004). Genetic analyses in Drosophila are consistent with such a 
timer model in that null mutants for Mad2 and BubR1 accelerate the traverse of mitosis 
to a slightly bigger extent than abrogation of Mad1 function (Buffin et al, 2007; Emre et 
al, 2011; Rahmani et al, 2009). It should also be noted that the contributions of Mad2 
and BubR1 to mitotic timing in flies appear to be minor and, remarkably, the SAC is not 
strictly required for undisturbed mitoses in this organism (Buffin et al, 2007), suggesting 
that there is no need to extend the mitotic duration beyond the duration of APC/C 
activation in the absence of the SAC in this organism.  
In the present thesis, injection of cells with antibodies directed at either C-Mad2 
or Mad1 triggered a striking mitotic acceleration. These results cannot readily be 
reconciled with the proposal that Mad2 (together with BubR1) is part of a “cytoplasmic 
mitotic timer”, which works independently of the SAC (Meraldi et al, 2004). Although we 
cannot formally exclude that functional neutralization by mAb microinjection triggers a 
different (and even stronger) phenotype than the reduction of the corresponding 
proteins by siRNA-mediated depletion, we suspect that the reported differences in the 
phenotypes observed after siRNA-mediated depletion of Mad1 or Mad2 (Meraldi et al, 
2004; our unpublished data) reflect differences in the functionality of residual protein 
levels. In particular, Mad2 depletion simultaneously affects both the KT-associated 
Mad1-bound Mad2 population (C-Mad2) and the cytoplasmic pool of Mad2 that awaits 
catalytic conversion (O-Mad2). Hence, even partial reduction of Mad2 readily causes 
acceleration of traverse through mitosis (Hubner et al, 2010). Conversely, Mad1 
depletion affects exclusively the catalyst (the Mad1:C-Mad2 complex) and, therefore, 
minor amounts of residual Mad1 might be sufficient to partly support the checkpoint, 
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thus preventing mitotic acceleration. A possible caveat of the study by Meraldi and 
colleagues is that SAC and “timer” functionalities have been assessed using two 
different assays; on one hand cells have been challenged with nocodazole and the 
mitotic index has been counted at an end point. In this case Mad1 depletion resulted in 
a lower mitotic index when compared to control samples. On the other hand, live cell 
imaging experiments were carried out to monitor mitotic timing. In the latter case, Mad1 
depletion did not accelerate the mitotic traverse beyond traverse speed of the bulk of 
control cells. When we monitored the effect of nocodazole challenge in a live cell 
imaging based assay, neither the Mad1 siRNA duplex published by Meraldi and 
colleagues, nor the one described herein (that produces larger protein downregulation), 
triggered a complete SAC abolishment but just displayed enhanced mitotic slippage (i.e. 
cells maintained the mitotic status for 4-6 h, data not shown). Our data suggest 
therefore that none of the Mad1 siRNA duplexes tested (for up to 72 h, including double 
transfection protocols) triggered a complete SAC abrogation, easily explaining the lack 
of mitotic timing acceleration.   
A recent study has also implicated the SAC kinase Mps1 in the regulation of 
mitotic timing suggesting that Mps1 is also required during interphase to form an 
anaphase inhibitor in a KT independent manner (Maciejowski et al, 2010). However, as 
our present data demonstrate that functional abrogation of Mad1:C-Mad2 also 
accelerates mitotic progression, we would predict that complete neutralization of any 
SAC component, including Mps1, will translate into faster progression through mitosis. 
Most importantly, the consequences of Mps1 inhibition were indistinguishable, 
regardless of whether the kinase was inhibited already during interphase or only during 
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mitosis. Thus, interphase activity of Mps1 does not significantly contribute to the timing 
of mitotic progression. Collectively, our results on the role of Mad1:C-Mad2 and Mps1 
should prompt a reconsideration of the distinction between SAC and mitotic timer.  
What determines then the mitotic duration in the absence of the SAC? Rise and 
fall of CDK1 activity drive eukaryotic cells in and out of mitosis. Delaying Cyclin B1 
degradation prolongs CDK1 activity in an unscheduled fashion, leading to an extended 
mitotic duration (Wolf et al, 2006), whereas the premature inhibition of CDK1 activity 
triggers mitotic exit (Potapova et al, 2006). Crucial events triggered by firing of CDK1 
are nuclear envelope breakdown and APC/C activation; live cell imaging analyses have 
shown that these two events are tightly coupled in a temporal fashion, as Cyclin A 
degradation commences upon NEBD (Di Fiore & Pines, 2010; Gavet & Pines, 2010a; 
Gavet & Pines, 2010b). Cyclin B1 and Cyclin A degradation at a single cell level display 
nearly identical degradation kinetics, with a variable time gap depending on completion 
of chromosome bi-orientation, provided by the SAC (Di Fiore & Pines, 2010 and J. 
Pines, unpublished data). Interestingly, the duration of mitotic traverse in the absence of 
the SAC and the time elapsed between disappearance of Mad2 signal from KTs and 
anaphase onset are nearly identical (Howell et al, 2000; Meraldi et al, 2004). In the 
absence of the SAC, the time gap between degradation of Cyclin A and B1 is abolished 
and the timing of anaphase onset might depend exclusively on the speed by which the 
APC/C can degrade Cyclin A and B1 following CDK1 firing.  
Regulation of Mad1:C-Mad2 through p31comet dependent capping 
Considering the central role of the Mad1:C-Mad2 complex in SAC signaling it is 
clearly important to understand its regulation in time and space. On the one hand, KTs 
provide an essential microenvironment for the activity of the Mad1:C-Mad2 complex, as 
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indicated by the observation that the complex is removed from KTs in a dynein-
dependent manner upon SAC silencing (Howell et al, 2001) and interference with this 
removal generates a SAC-dependent arrest (Gassmann et al, 2010; Griffis et al, 2007). 
On the other hand, SAC signaling is known to be inhibited by p31comet (Habu et al, 
2002; Xia et al, 2004). The work carried out during this thesis provides further insight 
into the role of this protein. Immunostaining with CM2276 revealed that the accessibility 
of C-Mad2 is controlled by p31comet at multiple locations. In particular, our siRNA 
experiments show that the dimerization interface of C-Mad2 is masked by p31comet at 
NPCs and spindle poles. The facts that p31comet siRNA could lead to unscheduled 
formation of Mad2:Cdc20 complex in interphase and to a metaphase arrest in mitosis 
(data not shown and this work, respectively) are consistent with the notion that Mad1:C-
Mad2 that accumulates at any subcellular structure is capable of catalysis and this has 
to be suppressed by reducing the availability of the C-Mad2 dimerization interface. 
More surprisingly, p31comet could associate with Mad1:C-Mad2 also during the 
SAC at KTs. In support of this conclusion, p31comet could be detected at KTs (Habu et 
al, 2002; this study). This raises the question of why a protein implicated in silencing of 
the SAC associates with the catalytic source of the SAC signal already during 
prometaphase. One possible explanation is that p31comet begins to cap and 
functionally inactivate individual C-Mad2 proteins as soon as a threshold of bipolar MT 
attachment to KTs has been reached, perhaps in preparation for subsequent stripping 
of the Mad1:C-Mad2:p31comet complex from KTs. The fact that p31comet localization 
as well as p31comet dependent masking could be observed not only in unperturbed 
prometaphases, but also in nocodazole arrested cells (data not shown) seems to 
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exclude this possibility. Alternatively, it would be premature to exclude that p31comet 
may have not only an inhibitory but also an activating role in SAC signaling, similar to 
the dual role of securin in the regulation of separase (Hornig et al, 2002). Future studies 
will have to explore these possibilities.  
In addition, it will be important to better understand the role of posttranslational 
modifications in the formation and activity of KT-associated complexes (Burke & 
Stukenberg, 2008; Hewitt et al, 2010).   
Is there a Tpr-Mps1 axis controlling Mad1:C-Mad2? 
We could show that the detectability of C-Mad2 by CM2276 decreases more 
sharply upon Mps1 intra-mitotic inhibition compared to the decrease observed for Mad1. 
The facts that 1) depletion of p31comet by siRNA could revert this phenomenon (this 
work), 2) Mps1 sustains the SAC by promoting not only the localization but also the 
activity of Mad1:C-Mad2 at KTs (Hewitt et al, 2010) and 3) p31comet can be directly 
phosphorylated by Mps1 in vitro (A. Musacchio, personal communication), are 
consistent with the notion that Mps1 sustains the SAC by promoting the dissociation 
between Mad1:C-Mad2 and p31comet. This simple model is challenged by the 
observation that the sharp decrease of C-Mad2 detectability over Mad1 observed when 
using CM2276 following Mps1 intra-mitotic inhibition, can also be reproduced using 
CM22F12 (recognizing C-Mad2 regardless of its binding to p31comet, see Appendix) in 
the same conditions (Conrad von Schubert). This raises the possibilities that abrogation 
of Mps1 activity is either promoting a local dissociation of C-Mad2 from Mad1 in a 
p31comet dependent manner or, most probably, promoting the assembly of an 
inhibitory complex comprising p31comet and other factors masking both the epitopes for 
both CM2276 and CM22F12. 
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The KTs localization of both Mad1 and Mad2 has become widely accepted as a 
marker for the lack of KT-MT attachment (see Maresca & Salmon, 2010 for review). The 
two proteins also tightly interact with each other, resisting up to 4 M urea and 2 M NaCl 
(Sironi et al, 2001). Also, Mad1 is saturated with Mad2 in the cell (Chung & Chen, 2002; 
Shah et al, 2004). It is therefore not surprising that in most circumstances the presence 
of Mad1 at KTs determines the simultaneous presence of Mad2. Exceptions to this 
include siRNA depleted cells for the proteins PICH and Tao1 (Baumann et al, 2007; 
Draviam et al, 2007) and cells in which Mps1 activity has been inhibited following KT-
recruitment of Mad1 and Mad2 (Hewitt et al, 2010). In the case of PICH and Tao1 
siRNA, the selective loss of Mad2 but not Mad1 from KTs appeared to depend on a 
downregulation of Mad2 mRNA induced by a subset of the siRNA duplexes targeting 
PICH and Tao1 (Hubner et al, 2010; Westhorpe et al, 2010) and not on an induced 
dissociation between Mad1 and Mad2, as originally suggested (Baumann et al, 2007; 
Draviam et al, 2007). For the intra-mitotic inhibition of Mps1, the lack of KT detection of 
Mad2 by immunostaining has been shown to correlate with a selective loss of O-Mad2 
but not of C-Mad2 from KTs, prompting the authors to propose that Mad2 antibody 
staining in their setting primarily recognized O-Mad2 (Hewitt et al, 2010). Using CM2276 
we could also observe a decrease in C-Mad2/Mad1 fluorescence in similar experiments. 
We reasoned that an abrogation of Mad2 conformational dimerization at KTs could 
depend on an increased masking of the C-Mad2 dimerization interface by p31comet. 
The fact that the observed decrease of CM2276/Mad1 fluorescence could be reverted by 
p31comet siRNA lends strong support to this idea.  
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Another circumstance in which the KT localization of Mad1 and Mad2 could be 
uncoupled is the siRNA-mediated depletion of Tpr (Lince-Faria et al, 2009). Also in this 
case, the selective loss of Mad2 detection from KTs could be confirmed utilizing CM2276 
and could be reverted by co-depletion with p31comet, suggesting that Tpr siRNA may 
act on Mad1:C-Mad2 similarly to the Mps1 intra-mitotic inhibition, i.e. through p31comet. 
The idea that Tpr and Mps1 both act in promoting the sustained activity of Mad1:C-
Mad2 in the same pathway finds experimental support in the observation that Mps1 
appeared delocalized from KTs in fly cells depleted of Tpr (Lince-Faria et al, 2009). 
Whether this is the case also in human cells will have to be tested, but the observation 
that overexpression of catalytically inactive Mps1 led to a massive accumulation of Tpr 
at prometaphase KTs of human cells (that is usually undetectable at those structures, 
Helder Maiato´s group, in preparation) supports the notion that there is a functional 
interplay at KTs between Tpr and Mps1 that will require further investigation.   
The body of evidence discussed circumstantiates the notion that Tpr promotes 
KT localization of Mps1 which in turn may be required for the inhibitory phosphorylation 
of p31comet leading to its dissociation from Mad1:C-Mad2. However, this analysis has 
so far neglected that the Tpr siRNA duplex employed for this work also affected the 
protein levels of Mad2. Unlikely PICH and Tao1 depletions, Tpr siRNA did not impact on 
Mad2 mRNA levels (H. Maiato, personal communication). Since Tpr binds Mad2 directly 
(Lee et al, 2008), it is possible that Mad2 will become less stable in the absence of its 
interacting partner Tpr and contribution of the latter to the SAC could therefore be 
pleiotropic. Even a minor decrease in Mad2 protein levels is sufficient to compromise 
SAC signaling and it would not be necessary to invoke further effects beside the Mad2 
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downregulation for explaining the SAC function of Tpr. Nevertheless, both the CM2276 
undetectability of C-Mad2 at KTs and the acceleration of mitotic timing observed upon 
Tpr siRNA could be partly rescued by co-depletion of p31comet and they could both be 
phenocopied by small molecule inhibition of Mps1 within minutes, situation in which the 
Mad2 protein downregulation is unlikely to play a role. Future approaches such as the 
identification of the different Tpr determinants responsible for the different functions 
(such as interaction with Mad2 and promotion of Mps1 KT localization) will allow better 
comprehending the role of Tpr in SAC signaling.   
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Materials and Methods 
Cloning procedures  
For cloning of p31comet (MAD2L1BP), a cDNA clone (IRAUp969G0825D) was 
obtained from the Deutsches Ressourcenzentrum für Genomforschung (RZPD). The 
p31 coding sequence was amplified with the following oligonucleotides: 
CGGGATCCGCGGCGCCGGAGGCGGA and 
CCGCTCGAGTCATTCACTCGCGGAAGCC. A BamHI/XhoI digest of the PCR product 
was cloned into a pET28a(+) vector (Novagen) and a pcDNA3.1 vector (Invitrogen) that 
had been modified replacing the CMV with the SV40 promoter, carrying N-terminal 6His 
and 3xmyc tags, respectively. p31cometQA-FA (Q83A-F191A; Yang et al., 2007) was 
generated by using the following oligonucleotides 
(AAGCATATCATGTATGCACGCCAGCAGCTCCCT and 
TGTTTGCGCCGTCTCGCCCGAGCCATATTCATG with their reversed complements) 
with a QuickChange Site-Directed Mutagenesis kit (Stratagene). All other plasmids were 
described elsewhere  or were generated with similar molecular cloning approaches by 
modifying existing plasmids that have been already described (Mapelli et al., 2006; 
Mapelli et al., 2007; Martin-Lluesma et al., 2002). 
Production and purification of recombinant proteins and antibodies  
A polyclonal antibody against p31comet (741212) was generated by 
immunization of rabbits (Charles River Laboratories) with 6His-p31comet expressed in 
E. coli. IMAC purification of p31comet was performed using a HisTrap HP column (GE 
Healthcare), following the manufacturer´s instructions. After purification, p31comet was 
dialyzed against 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% Glycerol, 2 mM β-
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mercaptoethanol. The p31comet Ab was purified by Affi-Prep protein A matrix (Bio-Rad 
Laboratories).  
Anti-pS490 Mad1 polyclonal antibody was generated by Anna Santamaria by 
immunizing rabbits with a KLH-conjugated phosphopeptide (H-CSAEQpSFLFS-OH) 
and the serum (3rd “bleed” of rabbit 833976) was used for immunofluorescence and 
Western blot experiments.  
CM2276 (clone 107-276) has been generated by Andreas Uldschmid. Briefly, 
CM2276 (IgG1k) was generated against GST-tagged full-length human Mad2 by 
repeated subcutaneous injection of 100 µg of antigen into Balb/c mice using aluminium 
hydroxide as an adjuvant. Spleen cells were fused with PAIB3Ag81 mouse myeloma 
cells. Supernatant screening was performed by ELISA.  
Mad1 monoclonal antibodies (117-468 and 117-470, both IgG1) were generated 
by Andreas Uldschmid against full-length recombinant MBP-Mad1 expressed in E. coli. 
MBP-Mad1 was purified using an MBPTrap HP column (GE Healthcare) and 
immunization of mice has been carried out as for CM2276.  
CM22F12 has been generated against IMAC purified 6His-tagged full length 
human Mad2. Injection and supernatant primary screening (performed using GST-
tagged full length human Mad2) were performed by Moravian Biotechnology. See 
Appendix I for characterization. 
Myc mAb (9E10) (Evan et al., 1985) has been described previously. All mAbs 
were purified using HiTrap protein G HP columns (GE Healthcare).  
6His-Mad2WT, 6His-Mad2mutants were expressed purified as follows: BL21-
CodonPlus(DE3)-RIL (Novagen) were transformed with plasmids encoding 6His-
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Mad2WT/mutants (Sironi et al., 2001, Mapelli et al., 2007) and grown in LB medium at 30°C 
until O.D.600 = 0.5 was reached. Bacteria were grown further at 25 °C until O.D.600 = 
0.75 was reached. Induction was then performed by addition of 0.5 mM IPTG for 7h at 
23 °C. Lysis and IMAC purification using a HisTrap HP column (GE Healthcare) were 
performed at 4°C. Recombinant proteins were stored at -80 °C in PBS. GST-Cdc20111-
138 was purified as described previously (Mapelli et al., 2006). 
Competition assays 
For GST-pulldown experiments, a complex between GST-Cdc20111-138 and His-
tagged Mad2WT was generated on Glutathione Sepharose 4B beads (GE Healthcare) as 
described before (Mapelli et al, 2007). Competition in binding to C-Mad2 was assessed 
by adding CM2276 to the beads at 0.2 µM together with p31comet at 0.6, 3.6 or 9 µM. 
The corresponding negative control was performed by replacing p31comet with equal 
concentrations of hSpindly1-444. For the CM2276 and Mad2∆C competition, Mad2∆C was 
added to the beads at a concentration of 0.35 µM together with CM2276 at 
concentrations of 0.15, 0.45 or 1.35 µM. The corresponding negative control was 
performed by replacing CM2276 with equal concentrations of Mad1 mAb (117-468). For 
the sequential absorption experiment, Mad2∆C and CM2276 were used at concentrations 
of 0.35 and 0.9 µM, respectively.  
Peptide spots array synthesis and antibody binding assay 
Peptide arrays were constructed using standard F-moc chemistry on a MultiPep 
robotic spotter according the manufacturer’s instructions (Intavis). Antibody binding to 
candidate peptides was performed incubating primary antibodies in milk/PBST 5%, w/v, 
followed by HRP-secondary antibody detection as in normal Western blot experiments.   
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In vitro kinase assay  
In vitro phosphorylation of Mad1 was carried out at 30°C using 500 ng of 
recombinant MBP-Mad1 and 100 ng of Plk1 kinase in a total volume of 30 μL of BRB80 
kinase reaction buffer (80 mM Pipes pH 6.8, 1 mM MgCl2, 1 mM EGTA). Reactions 
were supplemented with 10 µM ATP and 2 µCi γ-32P-ATP (Amersham Pharmacia 
Biosciences, Piscataway, NJ). Reactions were stopped by addition of sample buffer. 
Samples were then resolved by SDS-PAGE and visualized by autoradiography and 
Western blotting using Mad1-pS490 antibody. 
Cell culture and synchronization  
Cells were cultured at 37°C, in a 5% CO2 atmosphere in DMEM (Gibco), 
supplemented with 10% heat-inactivated fetal calf serum (FCS) and 
penicillin/streptomycin (100 IU/ml and 100 μg/ml, respectively). For synchronization, 
thymidine (2 mM), nocodazole (50 ng/ml) (both Sigma Aldrich), MG132 (10 µM, 
Calbiochem), Mps1-IN1 (10 µM, kindly provided by N.S. Gray), RO-3306 (9 µM, Enzo 
Life Science), Monastrol (150 µM, Mayer et al, 1999) and TAL (1 µM, Santamaria et al, 
2007) were used as described in the figure legends. RO-3306 was used on HeLa Kyoto 
mCherry-H2B cells due to a better reversibility of the CDK1 inhibition observed in this 
cell line.  
SILAC labeling of cultured cells  
For SILAC labeling, HeLaS3 cells were cultured in DMEM formulated with either 
unlabeled L-lysine and L-arginine or labeled 13C6 15N4 –L-arginine and 13C6 15N2-L-lysine 
(Cambridge Isotope Laboratories) at the concentration of 42 and 72 µg/ml respectively, 
and supplemented with 10% dialyzed fetal bovine serum, 100 units/ ml penicillin, and 
100 µg/ml streptomycin. Unlabeled and labeled HeLaS3 cells were synchronized in 
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mitosis as described in the figure legends. For the assessment of the Plk1 
responsiveness of phosphorylation sites, cells were pre-synchronized by single 
thymidine arrest and released in media containing either TAL or Monastrol for 14 hours.  
Transient transfections of plasmid DNA and siRNA duplexes 
Plasmid transfections were performed for 36 h using TransIT-LT1 reagent (Mirus 
Bio Corporation) according to the manufacturer’s instructions. siRNA duplexes were 
transfected using Oligofectamine (Invitrogen) as described previously (Chan et al, 
2009). The following siRNA duplexes were purchased from QIAGEN: Mad1-3´UTR-1 
(CCACAGGGCAGCAGCAUGA) and Mad1-3´UTR-2 (CUGCUUGGCCUGACCUGCA); 
p31comet-1 (GAAGAUUGGUUUCGACCCA), p31comet-2 
(AUUCAUGGCUGAUGCCUUU) were described previously as part of a SmartPool 
(Reddy et al, 2007) and used here independently. The Mad2 (Martin-Lluesma et al, 
2002), Tpr (Lince-Faria et al, 2009) and control Gl2 duplexes (Elbashir et al, 2001) were 
described previously. Different siRNA transfections were performed for the following 
times: p31comet, 48 h; Mad2, 48 h; Tpr, 72 h. For Mad1 depletion that was performed 
by combining Mad1-3´UTR-1 with Mad1-3´UTR-2 duplexes, transfecting cells twice at 0 
and 24 h for a total of 60 h.   
Cell extracts, Western blots and immunoprecipitations 
Cell lysates and Western blot analysis were performed as described using lysis 
buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5% IGEPAL CA-630) containing 1 mM 
DTT, 30 µg/ml RNase A, 30 µg/ml DNase, protease (EDTA-free Tablet, Roche) and 
phosphatase (Sigma, cocktails 1 and 2) inhibitors. The lysis buffer was applied on dried 
cell pellets for 30 minutes on ice. Following vigorous pipetting, lysates were clarified by 
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10 minutes centrifugation at 20.000 g at 4°C and the supernatants were further 
processed.  
 Immunoprecipitations against purified Mad2 wild type and mutants were 
performed using 10 µl of solid Affi-Prep protein A matrix (Bio-Rad Laboratories) pre-
coupled with 1 µg/µl of antibody per condition. 0.5 ml of Tris lysis buffer containing 20 or 
80 µg of Mad2 (when comparing Mad2WT with Mad2L13Q and Mad2V193N or Mad2WT with 
Mad2RQ, respectively) was added to the beads and incubated at 4°C for 45 min. 
Immunoprecipitations on cell lysates were performed using 20 µl of solid beads 
chemically crosslinked to 1 µg/µl of antibody against 2 mg of clarified cell lysate for 2 h 
at 4°C. The beads were washed three times with Tris lysis buffer and bound species 
were resolved by SDS–PAGE. The following antibodies were used for Western blot: 
rabbit anti Mad2 (Bethyl Laboratories, cat. N. A300-301A, 1 µg/ml), rabbit anti Cdc20 
(Santa Cruz Biotechnology, cat. N. sc-8358, 1 µg/ml), rabbit anti p31comet (741212, 1 
µg/ml), mouse anti Mad1 (clone 117-470, 2 µg/ml), mouse anti α-tubulin (Sigma-Aldrich, 
cat. N. T9026, 0.2 µg/ml), mouse anti BubR1 (clone 68-3-9 2 µg/ml, Elowe et al, 2007), 
mouse anti CDC27 (BD Transduction Laboratories, cat. 610454, 0.5 µg/ml), mouse anti 
Myc (clone 9E10, 1 µg/ml Evan et al, 1985), rabbit anti Tpr (Bethyl Laboratories, cat. N. 
A300-825A, 2 µg/ml), rabbit anti Mad1-pS490 (3rd “bleed” of rabbit 833976, dilution 
1:500). Primary antibodies were detected using HRP-conjugated goat secondary 
antibodies (Bio Rad) and the ECL (Pierce) fluorescence was detected using a LAS-
3000 scanner (Fujifilm).  
Mass spectrometry 
Mass spectrometry analysis was performed as described previously (Dou et al, 
2011), with the assistance of Kalyan Dulla and Roman Körner. Briefly, CM2276 IPs were 
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performed against 30 mg of pre-cleared (using mouse unspecific IgG IP) lysate using 
200 µl of beads coupled to 1 µg/µl of antibody. Beads were washed three times in lysis 
buffer and resuspended in NuPAGE sample buffer (Invitrogen). samples were 
separated by a 4–12% NuPAGE gel (Invitrogen) and Coomassie Brilliant Blue (CBB)-
stained protein bands were in-gel digested by trypsin (sequencing grade, Roche, 
Germany) as described (Shevchenko et al, 1996). Phosphorylated peptides were 
enriched using TiO2 affinity purification with glycolic acid as a modifier (Jensen & 
Larsen, 2007). Subsequently, tryptic peptides were analyzed by nanoLC-MS/MS using 
a nanoACQUITY ultra performance liquid chromatography system (Waters, U.K.) 
coupled to an LTQOrbitrap (Thermo, Germany). Samples were injected onto a silica 
capillary column (New Objective, U.S.A.) packed with 3-mm ReproSil-Pur C18-AQ (Dr. 
Maisch GmbH, Germany). Peptides were separated by a stepwise 110-min gradient of 
0–100% between buffer A (0.2% formic acid in water) and buffer B (0.2% formic acid in 
acetonitrile) at a flow rate of 200 nL/min. The mass spectrometer was operated in data 
dependent MS/MS mode to automatically switch between MS survey and MS/MS 
fragmentation scans of five most abundant precursor ions. Peak lists were generated 
using DTA supercharge (Schulze & Mann, 2004) and searched using the Mascot 
(Matrix Science, UK) software package against the human International Protein Index 
(IPI) database (http://www.ebi.ac.uk/IPI/IPIhelp.html) with carbamidomethyl cysteine as 
a fixed modification and oxidized methionine, phosphorylation (S,T,Y), 13C6 15N4 -L-
arginine, and 13C6 15N2-L-lysine as variable modifications. Searches were performed 
with a precursor mass tolerance of 5 ppm and fragment ion tolerances of 0.7 Da and 
identified phosphorylation sites were further validated by visual inspection of MS/MS 
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spectra. For phosphopeptide quantification, the ratios between the monoisotopic peaks 
of labeled and unlabeled forms of phosphopeptides were calculated by MSQuant 
(Schulze & Mann, 2004). 
Immunofluorescence microscopy and fluorescence intensity measurements  
HeLaS3 cells were grown on coverslips, simultaneously fixed and permeabilized 
for 10 min at room temperature (RT) in PTEMF buffer, as described previously (Chan et 
al, 2009). For cytosolic pre-extraction, PTEMF buffer devoid of fomaldehyde was used 
for 60 sec., followed by normal PTEMF fixation. Mad1/C-Mad2 co-staining was 
performed as follows: C-Mad2 mAb (107-276, 4 µg/ml) was incubated on coverslips for 
1 h at RT. Either a Cy3- or Cy5-conjugated donkey anti–mouse secondary antibody was 
used (Dianova, 1:1000). Myc-p31comet and Myc-Mad2∆C transfected cells have been 
identified through primary rabbit anti-c-Myc incubation (Santa Cruz Biotechnology, A-14, 
1 µg/ml), followed by Cy2- or Cy5-conjugated donkey anti–rabbit (Dianova, 1:1000). 
Extensive washing was performed and mouse anti Mad1 (117-468), directly coupled to 
Alexa Fluor 488 (Invitrogen), was added (10 µg/ml) together with DAPI (2 μg/ml) for 1 h. 
Images were acquired using a DeltaVision Olympus IX71 microscope equipped with a 
60x/1.42 oil objective. Collection and processing of acquired images was carried out 
using Softworx (Applied Precision, LLC). Samples were examined with optical sections 
acquired 0.4 μm apart in the z-axis, deconvolved and projected into a single plane 
image using the Softworx software (Applied Precision, LLC). Images were processed in 
Adobe Photoshop CS3 and figures were assembled using Adobe Illustrator CS4 (Adobe 
Systems). 
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After antibody microinjection, DNA and Cyclin B1 were stained with DAPI and 
Cyclin B1 mAb (clone GNS3, Millipore) directly coupled to Alexa Fluor 488 (10 µg/ml), 
respectively, for 1h.  
When using the HeLa-Kyoto-LAPGFP-mouse-Mad2 cell line (Hubner et al, 2010; 
Poser et al, 2008), the localization of LAPGFP-mouse-Mad2 was monitored by visualizing 
the GFP flurescence directly, following PTEMF fixation.  
In order to visualize Mad1 phosphorylation on S490 in intact cells, Mad1-pS490 
antibody (3rd “bleed” of rabbit 833976, 1:500) was used in combination with Mad1 mAb 
(117-468, 1 µg/ml) and CREST antibodies (serum by Immunovision, 1:1000), followed 
by secondary antibody detection.   
For quantitation of fluorescence intensities, at least 20 round “regions of interest 
(ROIs)” of equal size were selected around KTs in each cell using ImageJ. Average 
fluorescence intensities were measured for each ROI, the average background 
fluorescence was subtracted and the calculated fluorescence ratios were normalized to 
control and displayed in box-and-whisker plots using SigmaPlot. 
Antibody microinjection 
Antibody injection was performed using Femtotips II capillaries operated on a 
FemtoJet microinjector (Eppendorf). Antibodies were injected at a needle concentration 
of 1-2 mg/ml in PBS in the presence of 1.66 mg/ml Texas Red dextran or Alexa Fluor 
488 dextran (both 10.000 MW, Invitrogen). Each injection was performed for 0.2-0.3 sec 
with injection and compensation pressures of 15 hPa. To assess the SAC functionality 
and effects on mitotic timing upon mAb microinjection, HeLaS3 H2B-GFP (Sillje et al, 
2006) cells or HeLa Kyoto H2B-mCherry (Neumann et al, 2010) were seeded on 35 mm 
µ-Dishes or coverslips and synchronized as described in the corresponding figure 
		 97
legends. Different mAbs were injected at different grid coordinates within the same plate 
or on different coverslips and phenotypes were analyzed by live cell imaging or 
immunofluorescence microscopy. 
Time-lapse microscopy 
Cells were imaged using a Nikon ECLIPSE Ti microscope equipped with a 
CoolLED pE-1 excitation system and a 20x/0.75 air Plan Apo objective (Nikon). Images 
were acquired at multiple positions every 3 min. GFP/mCherry fluorescence and DIC 
images were acquired at each time point with 20 msec and 2 msec exposure times, 
respectively. Texas Red/Alexa Fluor 488 fluorescence was imaged every 5 time points 
with a 40 msec exposure. MetaMorph 7.7 software (MDS Analytical Technologies) was 
used to collect and process data. 
Size exclusion chromatography followed by immunoprecipitation 
Synchronized HeLaS3 cells were lysed as described in the “Cell extracts, 
Western blots and immunoprecipitations” section. For Superdex 200 chromatography, 1 
ml of clarified lysate containing 10 mg of total protein extract was loaded on a Superdex 
200 16/60 column (GE) using an Äkta Explorer FPLC system (Amersham). An isocratic 
elution was performed at 4°C applying a constant flow of 1.1 ml/min of 20 mM Tris-HCl, 
pH 7.4, 150 mM NaCl. Fractions were collected every 4 ml; protease and phosphatase 
inhibitors were added to each fraction as to the lysis buffer. Each fraction was 
subdivided in a 1.3 ml part and a 2.7 ml part, destined to trichloroacetic acid (TCA) 
precipitation and IP, respectively. IP was performed for 2 hours at 4°C using 20 µl of 
solid protein A beads (BioRad), previously coupled and cross-linked to the CM2276 at 1 
µg/µl. Beads were washed 3 times with 0.5 ml of elution buffer and resuspended in 30 
		 98
µl of Laemmli buffer. TCA precipitated protein pellets were resuspended in 80 µl of 
Laemmli buffer. 10 µl were further analyzed by SDS-PAGE and Western blot. 
For Superose 6 chromatography, 300 µl of 10 mg/ml clarified HeLaS3 mitotic 
lysate (nocodazole) were loaded on a Superose 6 10/300 GL column and an isocratic 
elution was performed at 4°C applying a constant flow of 0.4 ml/min of 20 mM Tris-HCl, 
pH 7.4, 150 mM NaCl. Fractions of 650 µl were collected; protease and phosphatase 
inhibitors were added to each fraction as to the lysis buffer. Half of each fraction was 
destined to trichloroacetic acid (TCA) precipitation and half was, after pooling of relevant 
fractions, probed by IP with CM2276 Ab. Samples were processed as for the Superdex 
200 chromatography and 10 µl were further analyzed by SDS-PAGE and Western blot. 
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Appendix  
Generation of additional antibodies to Mad2  
Large part of this work is based on the serendipitous discovery of a monoclonal 
antibody recognizing selectively the closed conformer of Mad2. Despite the availability 
of several Mad2 antibodies (commercially or otherwise), none of them has been, to the 
best of our knowledge, thoroughly characterized for its preference for binding the open, 
closed or both conformers of Mad2 with the exception of CM2276. One sheep polyclonal 
Mad2 antibody has been proposed to recognize selectively the open conformer of Mad2 
based on immunofluorescence results, but this notion has not been directly tested in 
biochemical assays and the epitope(s) of this antibody remain unknown (Hewitt et al, 
2010). Therefore we used our purified recombinant Mad2-WT protein to immunize 
rabbits and mice, in order to obtain additional polyclonal and monoclonal Mad2 
antibodies, respectively. Whereas the rabbit injection protocol did not result in any 
serum capable of recognizing cellular endogenous Mad2, the hybridoma supernatant 
screening for Mad2 mAbs resulted in one positive hit, clone 2F12. The injection protocol 
was performed with His-tagged Mad2, whereas the screening was performed using 
GST-tagged Mad2 in a dot blot-based assay. Further characterization showed that the 
clone 2F12 (IgG1) can recognize endogenous Mad2 in both immunofluorescence and 
immunoprecipitation, but not in Western blot (see below). These data support the notion 
that mAb 2F12 recognizes a conformational rather than a linear epitope on Mad2. In 
immunoprecipitation experiments 2F12 was unable to recognize O-Mad2, showing 
therefore its specificity for Closed-Mad2. We named therefore this antibody CM22F12. 
Similarly to CM2276, CM22F12 could not immunoprecipitate free Mad2 isolated obtained 
from a cell lysate by size  
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Figure 38. 2F12 (CM22F12) recognizes selectively C-Mad2. (A) Purified Mad2WT (WT), Mad2L13Q 
(Closed) and Mad2V193N (Open) were immunoprecipitated (IP) with CM2276 or with CM22F12. Inputs and IPs 
were analyzed by Coomassie Brilliant Blue staining. (B) Western blots on samples obtained from TCA 
precipitations (Inputs), CM2276 IP and CM22F12 IP on fractions obtained as described in Fig. 17A, following 
synchronization as described in Fig. 17B. Western blots were performed with rabbit Mad2 polyclonal 
antibody. (C) Immunoprecipitations (IPs) were performed with unspecific CM2276 or CM22F12 from HeLaS3 
lysate obtained from cells arrested with nocodazole. Input and IPs were analyzed by Western blot with 
the indicated antibodies. (D) HeLaS3 cells were fixed with PTEMF. After fixation, C-Mad2 was stained 
with CM2276, followed by secondary antibody incubation. After extensive washing, co-staining with Mad1 
mAb directly coupled to Alexa Fluor 488 and CM22F12 directly coupled to Alexa 647 was performed. DNA 
was visualized with DAPI (blue). Insets show enlarged views of a Mad1:C-Mad2 positive KT and the 
surrounding nuclear envelope.  
 
exclusion chromatography, confirming that unliganded/free-Mad2 adopts the open 
conformation in living cells. In stark contrast to CM2276, CM22F12 could readily co-
immunoprecipitate p31comet from a human cell lysate, demonstrating that the epitope 
recognized by CM22F12 is not mapping on the dimerization interface (Fig. 38C). 
Interestingly, when used in immunofluorescence experiments, Mad22F12 could more 
readily recognize Mad2 at NPCs and spindle poles when compared to CM2276 (Fig. 
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38D). These data support the notion that Mad2 adopts the closed conformation at any 
subcellular site and that the lack of its recognition by CM2276 at NPCs and spindle poles 
depends on p31comet. Furthermore, the combined used of CM2276 and CM22F12 will 
allow testing simultaneously the presence of C-Mad2 and its association to p31comet in 
immunofluorescence based assays. 
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List of generated plasmids 
name tag gene insert vector comment 
LF 1 N-Myc p31-comet full-length pCDNA3.1 Mammalian expression, full-length 
LF 2 N-6His p31-comet full-length pET28a(+) Bacterial expression, full-length 
LF 3 N-Flag p31-comet full-length pCDNA3.1 Mammalian expression, full-length 
LF 4 N-6His p31-comet aa121-274 pET28a(+) Bacterial expression, C-term. High exp of 
unsoluble pr.
LF 5 GAL4-BD p31-comet full-length pGBD-C(I) Yeast two hybrid, BD-p31full length  
LF 6 N-Myc Mad1 aa485-584, R558H pCDNA3.1 Mammalian expression, aa485-584, 
R558H
LF 7 N-Flag Mad1 aa485-584, R558H pCDNA3.1 Mammalian expression, aa485-584, 
R558H
LF 8 GAL4-BD p31-comet full-length pFBT9' Yeast two hybrid, BD-p31full length  
LF 9 N-Myc Mad1 full-length, R558H, S233A pUNI10*p1226 Mammalian expression, full length, 
R558H, S233A
LF 10 N-Myc Mad1 full-length, R558H, S233D pUNI10*p1226 Mammalian expression, full length, 
R558H, S233D
LF 11 N-Myc Mad1 full-length, R558H, S490A pUNI10*p1226 Mammalian expression, full length, 
R558H, S490A
LF 12 N-Myc Mad1 full-length, R558H, S490D pUNI10*p1226 Mammalian expression, full length, 
R558H, S490D
LF 13 N-Myc Mad1 aa485-584, R558H, S490A pCDNA3.1 Mammalian expression, aa485-584, 
R558H, S490A
LF 14 N-Myc Mad1 aa485-584, R558H, S490D pCDNA3.1 Mammalian expression, aa485-584, 
R558H, S490D
LF 15 N-Flag Mad1 aa485-584, R558H, S490A pCDNA3.1 Mammalian expression, aa485-584, 
R558H, S490A
LF 16 N-Flag Mad1 aa485-584, R558H, S490D pCDNA3.1 Mammalian expression, aa485-584, 
R558H, S490D
LF017 mCherry p31-comet full length pcDNA3.1mCherryC mammalian expression 
LF018 AD HA INCENP 822-919 pACT2 Y2H
LF019 AD HA INCENP 790-897 pACT2 Y2H
LF020 Myc Mad1 full length wild-type pcDNA3.1 3xmyc-C mammalian expression 
LF021 6-His p31-comet S102A pET28a bacterial expression
LF022 6-His p31-comet f.l. S236A pET28a bacterial expression
LF023 6-His p31-comet f.l T242A pET28a bacterial expression
LF024 6-His p31-comet a.a. 1-120 pET28a bacterial expression
LF025 N-Myc p31-comet f.l. Q83A F191A pCDNA3.1 Mammalian expression, full-length 
LF026 6-His Mad2 full-length pET43 bacterial expression, gift from A. 
Musacchio
LF027 6-His Mad2 f.l. L13Q pET43 bacterial expression, gift from A. 
Musacchio
LF028 6-His Mad2 f.l. V193N pET43 bacterial expression, gift from A. 
Musacchio
LF029 6-His Mad2 f.l. R133E Q134A  pET43 bacterial expression, gift from A. 
Musacchio
LF030 GST p31-comet full length pGEX6p bacterial expression, full length 
LF031 GST Mad2 full length pGEX6p bacterial expression, full length 
LF032 6-His Mad2 f.l. F141A pET43 bacterial expression, gift from A. 
Musacchio
LF033 6-His Mad2 DeltaC10 pET43 bacterial expression, gift from A. 
Musacchio. Mad missing the C-terminal 
10 aa
LF034 6-His p31-comet f.l. Q83A F191A pET28a(+) bacterial expression, full length, deficient 
in the Mad2 binding
LF035 6-His Mad2 f.l. R133A pET43 bacterial expression, full length 
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name tag gene insert vector comment 
LF036 6-His Mad2 f.l. R133A L153A pET43 bacterial expression, full length 
LF037 6-His Mad2 f.l. R133A Y156A pET43 bacterial expression, full length 
LF038 N3*Myc Mad2 full length pcDNA3.1 mammalian expression, full length 
LF039 N3*Myc Mad2 f.l. L13Q pcDNA3.1 mammalian expression, full length 
LF040 N3*Myc Mad2 f.l. V193N pcDNA3.1 mammalian expression, full length 
LF041 GST Cdc20 111-138 pGEX6p bacterial expression, Mad2 binding part 
LF042 6-His Mad2 f.l. L13Q R133A pET43 bacterial expression, full length 
LF043 6-His Mad2 f.l. L13Q Q134A pET43 bacterial expression, full length 
LF044 6-His Mad2 f.l. L13Q F141A pET43 bacterial expression, full length 
LF045 6-His Mad2 f.l. L13Q R184A pET43 bacterial expression, full length 
LF046 N3*Myc Mad2 f.l. R133A pcDNA3.1 mammalian expression, full length 
LF047 N3*Myc Mad2 f.l. R133A L13Q pcDNA3.1 mammalian expression, full length 
LF048 N3*Myc Mad2 f.l. R133A V193N pcDNA3.1 mammalian expression, full length 
LF049 N3*Myc Mad2 WT siRNA resistant pcDNA3.1 carrying 5 silent mutations conferring 
resistance to oligo #531 
LF050 N3*Myc Mad2 L13Q siRNA resistant pcDNA3.1 carrying 5 silent mutations conferring 
resistance to oligo #531 
LF051 N3*Myc Mad2 V193N siRNA resistant pcDNA3.1 carrying 5 silent mutations conferring 
resistance to oligo #531 
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Aug. 2009, FEBS/EACR Advanced Lecture Course in Molecular Mechanisms in Signal 
Transduction and Cancer, Spetses, Greece. “Towards the in vivo visualization of Mad2 
conformers”. Poster and selected talk   
Awards and Scholarships 
Aug. 07-present IMPRS-LS (Max Planck Institute of Biochemistry) student 
membership, providing support in terms of travel grants, access to 
scientific and soft skill workshops and salary (partly)  
Aug. 2009 Prize for the best selected talk at FEBS/EACR Advanced Lecture 
Course in Molecular Mechanisms in Signal Transduction and 
Cancer, Spetses, Greece 
Academic Year 2006-2007 ZMBH fellowships for the Master work at the University of 
Heidelberg 
		 121
Academic Year 2006-2007 Socrates/Erasmus fellowships for the Master work at the 
University of Heidelberg 
Academic Year 2006-2007  Academic Merit Award of the Province of Bolzano, assigned to the 
best 80 university students resident in Alto Adige according to 
score of the final exam (110/110, with distinction)  
Academic Year 2005-2006  Academic Merit Award of the Province of Bolzano, assigned to the 
best 180 university students resident in Alto Adige according to 
the average score of the university exams (29.1/30) 
 
